Abstract
Entropy production rate is increased by several metabolic and thermodynamics abnormalities in neurodegenerative diseases (NDs). Irreversible processes are quantified by changes in the entropy production rate. This review is focused on the opposing interactions observed in NDs between the canonical WNT/beta-catenin pathway and PPAR gamma and their metabolic and thermodynamic implications. In amyotrophic lateral sclerosis and Huntington’s disease, WNT/beta-catenin pathway is upregulated, whereas PPAR gamma is downregulated. In Alzheimer’s disease and Parkinson’s disease, WNT/beta-catenin pathway is downregulated while PPAR gamma is upregulated. The dysregulation of the canonical WNT/beta-catenin pathway is responsible for the modification of thermodynamics behaviors of metabolic enzymes. Upregulation of WNT/beta-catenin pathway leads to aerobic glycolysis, named Warburg effect, through activated enzymes, such as glucose transporter (Glut), pyruvate kinase M2 (PKM2), pyruvate dehydrogenase kinase 1(PDK1), monocarboxylate lactate transporter 1 (MCT-1), lactic dehydrogenase kinase-A (LDH-A) and inactivation of pyruvate dehydrogenase complex (PDH). Downregulation of WNT/beta-catenin pathway leads to oxidative stress and cell death through inactivation of Glut, PKM2, PDK1, MCT-1, LDH-A but activation of PDH. In addition, in NDs, PPAR gamma is dysregulated, whereas it contributes to the regulation of several key circadian genes. NDs show many dysregulation in the mediation of circadian clock genes and so of circadian rhythms. Thermodynamics rhythms operate far-from-equilibrium and partly regulate interactions between WNT/beta-catenin pathway and PPAR gamma. In NDs, metabolism, thermodynamics and circadian rhythms are tightly interrelated.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- Acetyl-coA:
-
Acetyl-coenzyme A
- AD:
-
Alzheimer’s disease
- ALS:
-
Amyotrophic lateral sclerosis
- APC:
-
Adenomatous polyposis coli
- ARVC:
-
Arrthymogenic right ventricular dysplasia/cardiomyopathy
- Bmal1:
-
Brain and muscle aryl-hydrocarbon receptor nuclear translocator-like 1
- Clock:
-
Circadian locomotor output cycles kaput
- COX-2:
-
Cyclooxygenase-2
- Cry:
-
Cryptochrome
- Dsh:
-
Disheveled
- EMT:
-
Epithelial-mesenchymal transition
- Fzd:
-
Frizzled
- GK:
-
Glucokinase
- GLUT:
-
Glucose transporter
- GSK-3beta:
-
Glycogen synthase kinase-3beta
- HD:
-
Huntington’s disease
- LDH:
-
Lactate dehydrogenase
- LRP 5/6:
-
Low-density lipoprotein receptor-related protein 5/6
- MCT-1:
-
Monocarboxylate lactate transporter-1
- NDs:
-
Neurodegenerative diseases
- PD:
-
Parkinson’s disease
- PDH:
-
Pyruvate dehydrogenase complex
- PDK:
-
Pyruvate dehydrogenase kinase
- Per:
-
Period
- PFK-1:
-
Phosphofructokinase-1
- PPAR gamma:
-
Peroxisome proliferator-activated receptor gamma
- PGC-1alpha:
-
Peroxisome proliferator-activated receptor gamma coactivator-1 alpha
- PI3K-Akt:
-
Phosphatidylinositol 3-kinase-protein kinase B
- RORs:
-
Retinoid-related orphan receptors
- TCF/LEF:
-
T cell factor/lymphoid enhancer factor
- TZD:
-
Thiazolidinedione
- TCA:
-
Tricarboxylic acid
References
Abbott, R. D., Ross, G. W., White, L. R., Tanner, C. M., Masaki, K. H., Nelson, J. S., et al. (2005). Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology, 65(9), 1442–1446. https://doi.org/10.1212/01.wnl.0000183056.89590.0d.
Abe, M., Herzog, E. D., Yamazaki, S., Straume, M., Tei, H., Sakaki, Y., et al. (2002). Circadian rhythms in isolated brain regions. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 22(1), 350–356.
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997). β-catenin is a target for the ubiquitin–proteasome pathway. The EMBO Journal, 16(13), 3797–3804. https://doi.org/10.1093/emboj/16.13.3797.
Ahmadian, M., Suh, J. M., Hah, N., Liddle, C., Atkins, A. R., Downes, M., et al. (2013). PPARγ signaling and metabolism: The good, the bad and the future. Nature Medicine, 19(5), 557–566. https://doi.org/10.1038/nm.3159.
Alders, J., Smits, M., Kremer, B., & Naarding, P. (2009). The role of melatonin in sleep disturbances in end-stage Huntington’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 21(2), 226–227. https://doi.org/10.1176/jnp.2009.21.2.226.
Al-Harthi, L. (2012). Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders. Journal of Neuroimmune Pharmacology, 7(4), 725–730. https://doi.org/10.1007/s11481-012-9412-x.
Ali, T., & Kim, M. O. (2015). Melatonin ameliorates amyloid beta-induced memory deficits, tau hyperphosphorylation and neurodegeneration via PI3/Akt/GSk3β pathway in the mouse hippocampus. Journal of Pineal Research, 59(1), 47–59. https://doi.org/10.1111/jpi.12238.
Aliev, G., Priyadarshini, M., Reddy, V. P., Grieg, N. H., Kaminsky, Y., Cacabelos, R., et al. (2014). Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease. Current Medicinal Chemistry, 21(19), 2208–2217.
Almeida, M., Ambrogini, E., Han, L., Manolagas, S. C., & Jilka, R. L. (2009). Increased lipid oxidation causes oxidative stress, increased peroxisome proliferator-activated receptor-gamma expression, and diminished pro-osteogenic Wnt signaling in the skeleton. The Journal of biological chemistry, 284(40), 27438–27448. https://doi.org/10.1074/jbc.m109.023572.
Alvarez, A. R., Godoy, J. A., Mullendorff, K., Olivares, G. H., Bronfman, M., & Inestrosa, N. C. (2004). Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. Experimental Cell Research, 297(1), 186–196. https://doi.org/10.1016/j.yexcr.2004.02.028.
Ambacher, K. K., Pitzul, K. B., Karajgikar, M., Hamilton, A., Ferguson, S. S., & Cregan, S. P. (2012). The JNK- and AKT/GSK3β- signaling pathways converge to regulate puma induction and neuronal apoptosis induced by trophic factor deprivation. PLoS ONE, 7(10), e46885. https://doi.org/10.1371/journal.pone.0046885.
Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J., Shen, M., et al. (2011). Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science (New York, N.Y.), 334(6060), 1278–1283. https://doi.org/10.1126/science.1211485.
Anea, C. B., Zhang, M., Stepp, D. W., Simkins, G. B., Reed, G., Fulton, D. J., et al. (2009). Vascular disease in mice with a dysfunctional circadian clock. Circulation, 119(11), 1510–1517. https://doi.org/10.1161/circulationaha.108.827477.
Angers, S., & Moon, R. T. (2009). Proximal events in Wnt signal transduction. Nature Reviews Molecular Cell Biology. https://doi.org/10.1038/nrm2717.
Aziz, N. A., Anguelova, G. V., Marinus, J., Lammers, G. J., & Roos, R. A. C. (2010). Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington’s disease. Parkinsonism & Related Disorders, 16(5), 345–350. https://doi.org/10.1016/j.parkreldis.2010.02.009.
Aziz, N. A., Pijl, H., Frölich, M., Schröder-van der Elst, J. P., van der Bent, C., Roelfsema, F., et al. (2009). Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease. Journal of Neurology, 256(12), 1961–1965. https://doi.org/10.1007/s00415-009-5196-1.
Barros, L. F. (2013). Metabolic signaling by lactate in the brain. Trends in Neurosciences, 36(7), 396–404. https://doi.org/10.1016/j.tins.2013.04.002.
Barthel, A., Schmoll, D., & Unterman, T. G. (2005). FoxO proteins in insulin action and metabolism. Trends in endocrinology and metabolism: TEM, 16(4), 183–189. https://doi.org/10.1016/j.tem.2005.03.010.
Bass, J., & Takahashi, J. S. (2010). Circadian integration of metabolism and energetics. Science (New York, N.Y.), 330(6009), 1349–1354. https://doi.org/10.1126/science.1195027.
Bauernfeind, A. L., Barks, S. K., Duka, T., Grossman, L. I., Hof, P. R., & Sherwood, C. C. (2014). Aerobic glycolysis in the primate brain: Reconsidering the implications for growth and maintenance. Brain Structure & Function, 219(4), 1149–1167. https://doi.org/10.1007/s00429-013-0662-z.
Beaver, L. M., Klichko, V. I., Chow, E. S., Kotwica-Rolinska, J., Williamson, M., Orr, W. C., et al. (2012). Circadian regulation of glutathione levels and biosynthesis in Drosophila melanogaster. PLoS ONE, 7(11), e50454. https://doi.org/10.1371/journal.pone.0050454.
Bélanger, M., Allaman, I., & Magistretti, P. J. (2011). Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. Cell Metabolism, 14(6), 724–738. https://doi.org/10.1016/j.cmet.2011.08.016.
Benilova, I., Karran, E., & De Strooper, B. (2012). The toxic Aβ oligomer and Alzheimer’s disease: an emperor in need of clothes. Nature Neuroscience, 15(3), 349–357. https://doi.org/10.1038/nn.3028.
Benzinger, T. L. S., Blazey, T., Jack, C. R., Koeppe, R. A., Su, Y., Xiong, C., et al. (2013). Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease. Proceedings of the National Academy of Sciences of the United States of America, 110(47), E4502–E4509. https://doi.org/10.1073/pnas.1317918110.
Bero, A. W., Yan, P., Roh, J. H., Cirrito, J. R., Stewart, F. R., Raichle, M. E., et al. (2011). Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nature Neuroscience, 14(6), 750–756. https://doi.org/10.1038/nn.2801.
Berwick, D. C., & Harvey, K. (2011). LRRK2 signaling pathways: The key to unlocking neurodegeneration? Trends in Cell Biology, 21(5), 257–265. https://doi.org/10.1016/j.tcb.2011.01.001.
Berwick, D. C., & Harvey, K. (2012). The importance of Wnt signalling for neurodegeneration in Parkinson’s disease. Biochemical Society Transactions, 40(5), 1123–1128. https://doi.org/10.1042/bst20120122.
Besson, M. T., Alegría, K., Garrido-Gerter, P., Barros, L. F., & Liévens, J.-C. (2015). Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model. PLoS ONE, 10(3), e0118765. https://doi.org/10.1371/journal.pone.0118765.
Blackhall, L. J. (2012). Amyotrophic lateral sclerosis and palliative care: Where we are, and the road ahead. Muscle and Nerve, 45(3), 311–318. https://doi.org/10.1002/mus.22305.
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015). Oxidative stress and Parkinson’s disease. Frontiers in Neuroanatomy, 9, 91. https://doi.org/10.3389/fnana.2015.00091.
Bolaños, J. P., Almeida, A., & Moncada, S. (2010). Glycolysis: A bioenergetic or a survival pathway? Trends in Biochemical Sciences, 35(3), 145–149. https://doi.org/10.1016/j.tibs.2009.10.006.
Bonuccelli, U., Del Dotto, P., Lucetti, C., Petrozzi, L., Bernardini, S., Gambaccini, G., et al. (2000). Diurnal motor variations to repeated doses of levodopa in Parkinson’s disease. Clinical Neuropharmacology, 23(1), 28–33.
Boonen, R. A. C. M., van Tijn, P., & Zivkovic, D. (2009). Wnt signaling in Alzheimer’s disease: Up or down, that is the question. Ageing Research Reviews, 8(2), 71–82. https://doi.org/10.1016/j.arr.2008.11.003.
Borghammer, P. (2012). Perfusion and metabolism imaging studies in Parkinson’s disease. Danish Medical Journal, 59(6), B4466.
Borghammer, P., Chakravarty, M., Jonsdottir, K. Y., Sato, N., Matsuda, H., Ito, K., et al. (2010). Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: Probably even at early disease stages. Brain Structure & Function, 214(4), 303–317. https://doi.org/10.1007/s00429-010-0246-0.
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004). Stages in the development of Parkinson’s disease-related pathology. Cell and Tissue Research, 318(1), 121–134. https://doi.org/10.1007/s00441-004-0956-9.
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology, 137(1), 354–366. https://doi.org/10.1210/endo.137.1.8536636.
Bratic, A., & Larsson, N.-G. (2013). The role of mitochondria in aging. The Journal of Clinical Investigation, 123(3), 951–957. https://doi.org/10.1172/jci64125.
Breen, D. P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J. M., Reddy, A. B., et al. (2014). Sleep and circadian rhythm regulation in early Parkinson disease. JAMA neurology, 71(5), 589–595. https://doi.org/10.1001/jamaneurol.2014.65.
Bright, J. J., Kanakasabai, S., Chearwae, W., & Chakraborty, S. (2008). PPAR regulation of inflammatory signaling in CNS diseases. PPAR research, 2008, 658520. https://doi.org/10.1155/2008/658520.
Browne, S. E., Yang, L., DiMauro, J.-P., Fuller, S. W., Licata, S. C., & Beal, M. F. (2006). Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiology of Disease, 22(3), 599–610. https://doi.org/10.1016/j.nbd.2006.01.001.
Bunger, M. K., Wilsbacher, L. D., Moran, S. M., Clendenin, C., Radcliffe, L. A., Hogenesch, J. B., et al. (2000). Mop3 is an essential component of the master circadian pacemaker in mammals. Cell, 103(7), 1009–1017.
Butterfield, D. A., Abdul, H. M., Opii, W., Newman, S. F., Joshi, G., Ansari, M. A., et al. (2006). Pin1 in Alzheimer’s disease. Journal of Neurochemistry, 98(6), 1697–1706. https://doi.org/10.1111/j.1471-4159.2006.03995.x.
Cai, Y., Liu, S., Sothern, R. B., Xu, S., & Chan, P. (2010). Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson’s disease. European Journal of Neurology, 17(4), 550–554. https://doi.org/10.1111/j.1468-1331.2009.02848.x.
Calvo, J. R., González-Yanes, C., & Maldonado, M. D. (2013). The role of melatonin in the cells of the innate immunity: A review. Journal of Pineal Research, 55(2), 103–120. https://doi.org/10.1111/jpi.12075.
Cao, Y., Wang, H., Ouyang, Q., & Tu, Y. (2015). The free energy cost of accurate biochemical oscillations. Nature Physics, 11(9), 772–778. https://doi.org/10.1038/nphys3412.
Cardinali, D. P., Pagano, E. S., Scacchi Bernasconi, P. A., Reynoso, R., & Scacchi, P. (2013). Melatonin and mitochondrial dysfunction in the central nervous system. Hormones and Behavior, 63(2), 322–330. https://doi.org/10.1016/j.yhbeh.2012.02.020.
Carta, A. R., Frau, L., Pisanu, A., Wardas, J., Spiga, S., & Carboni, E. (2011). Rosiglitazone decreases peroxisome proliferator receptor-γ levels in microglia and inhibits TNF-α production: New evidences on neuroprotection in a progressive Parkinson’s disease model. Neuroscience, 194, 250–261. https://doi.org/10.1016/j.neuroscience.2011.07.046.
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., et al. (2002). Role of mitochondrial dysfunction in Alzheimer’s disease. Journal of Neuroscience Research, 70(3), 357–360. https://doi.org/10.1002/jnr.10389.
Cepeda, C., Starling, A. J., Wu, N., Nguyen, O. K., Uzgil, B., Soda, T., et al. (2004). Increased GABAergic function in mouse models of Huntington’s disease: Reversal by BDNF. Journal of Neuroscience Research, 78(6), 855–867. https://doi.org/10.1002/jnr.20344.
Chang, H.-C., & Guarente, L. (2013). SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell, 153(7), 1448–1460. https://doi.org/10.1016/j.cell.2013.05.027.
Chaturvedi, R. K., Adhihetty, P., Shukla, S., Hennessy, T., Calingasan, N., Yang, L., et al. (2009). Impaired PGC-1alpha function in muscle in Huntington’s disease. Human Molecular Genetics, 18(16), 3048–3065. https://doi.org/10.1093/hmg/ddp243.
Chaturvedi, R. K., & Beal, M. F. (2008). Mitochondrial approaches for neuroprotection. Annals of the New York Academy of Sciences, 1147, 395–412. https://doi.org/10.1196/annals.1427.027.
Chen, T. L. (2004). Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone, 35(1), 83–95. https://doi.org/10.1016/j.bone.2004.03.019.
Chen, H., & Chan, D. C. (2009). Mitochondrial dynamics—fusion, fission, movement, and mitophagy—in neurodegenerative diseases. Human Molecular Genetics, 18(R2), R169–R176. https://doi.org/10.1093/hmg/ddp326.
Chen, Y., Guan, Y., Liu, H., Wu, X., Yu, L., Wang, S., et al. (2012a). Activation of the Wnt/β-catenin signaling pathway is associated with glial proliferation in the adult spinal cord of ALS transgenic mice. Biochemical and Biophysical Research Communications, 420(2), 397–403. https://doi.org/10.1016/j.bbrc.2012.03.006.
Chen, Y., Guan, Y., Zhang, Z., Liu, H., Wang, S., Yu, L., et al. (2012b). Wnt signaling pathway is involved in the pathogenesis of amyotrophic lateral sclerosis in adult transgenic mice. Neurological Research, 34(4), 390–399. https://doi.org/10.1179/1743132812y.0000000027.
Chen, Y.-C., Wu, J.-S., Tsai, H.-D., Huang, C.-Y., Chen, J.-J., Sun, G. Y., et al. (2012c). Peroxisome proliferator-activated receptor gamma (PPAR-γ) and neurodegenerative disorders. Molecular Neurobiology, 46(1), 114–124. https://doi.org/10.1007/s12035-012-8259-8.
Chen, L., & Yang, G. (2014). PPARs integrate the mammalian clock and energy metabolism. PPAR research, 2014, 653017. https://doi.org/10.1155/2014/653017.
Chiang, M.-C., Chen, C.-M., Lee, M.-R., Chen, H.-W., Chen, H.-M., Wu, Y.-S., et al. (2010). Modulation of energy deficiency in Huntington’s disease via activation of the peroxisome proliferator-activated receptor gamma. Human Molecular Genetics, 19(20), 4043–4058. https://doi.org/10.1093/hmg/ddq322.
Chiang, M.-C., Cheng, Y.-C., Nicol, C. J., Lin, K.-H., Yen, C.-H., Chen, S.-J., et al. (2015). Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells. Experimental Cell Research, 338(2), 183–193. https://doi.org/10.1016/j.yexcr.2015.09.005.
Chiang, M.-C., Nicol, C. J., Cheng, Y.-C., Lin, K.-H., Yen, C.-H., & Lin, C.-H. (2016). Rosiglitazone activation of PPARγ-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress. Neurobiology of Aging, 40, 181–190. https://doi.org/10.1016/j.neurobiolaging.2016.01.132.
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., et al. (2008). The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature, 452(7184), 230–233. https://doi.org/10.1038/nature06734.
Chuquet, J., Quilichini, P., Nimchinsky, E. A., & Buzsáki, G. (2010). Predominant enhancement of glucose uptake in astrocytes versus neurons during activation of the somatosensory cortex. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 30(45), 15298–15303. https://doi.org/10.1523/jneurosci.0762-10.2010.
Cimini, S., Rizzardini, M., Biella, G., & Cantoni, L. (2014). Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis. Journal of Neurochemistry, 129(3), 413–425. https://doi.org/10.1111/jnc.12642.
Ciron, C., Lengacher, S., Dusonchet, J., Aebischer, P., & Schneider, B. L. (2012). Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function. Human Molecular Genetics, 21(8), 1861–1876. https://doi.org/10.1093/hmg/ddr618.
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., et al. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron, 48(6), 913–922. https://doi.org/10.1016/j.neuron.2005.10.028.
Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H., et al. (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature, 441(7097), 1162–1166. https://doi.org/10.1038/nature04779.
Clevers, H., & Nusse, R. (2012). Wnt/β-catenin signaling and disease. Cell, 149(6), 1192–1205. https://doi.org/10.1016/j.cell.2012.05.012.
Combs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000). Inflammatory mechanisms in Alzheimer’s disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 20(2), 558–567.
Coogan, A. N., Schutová, B., Husung, S., Furczyk, K., Baune, B. T., Kropp, P., et al. (2013). The circadian system in Alzheimer’s disease: Disturbances, mechanisms, and opportunities. Biological Psychiatry, 74(5), 333–339. https://doi.org/10.1016/j.biopsych.2012.11.021.
Coppola, G., Marmolino, D., Lu, D., Wang, Q., Cnop, M., Rai, M., et al. (2009). Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich’s ataxia. Human Molecular Genetics, 18(13), 2452–2461. https://doi.org/10.1093/hmg/ddp183.
Corona, J. C., & Duchen, M. R. (2015). PPARγ and PGC-1α as therapeutic targets in Parkinson’s. Neurochemical Research, 40(2), 308–316. https://doi.org/10.1007/s11064-014-1377-0.
Crowley, S. J., & Eastman, C. I. (2013). Melatonin in the afternoons of a gradually advancing sleep schedule enhances the circadian rhythm phase advance. Psychopharmacology (Berl), 225(4), 825–837. https://doi.org/10.1007/s00213-012-2869-8.
Csernus, V., & Mess, B. (2003). Biorhythms and pineal gland. Neuro Endocrinology Letters, 24(6), 404–411.
Cuadrado-Tejedor, M., Vilariño, M., Cabodevilla, F., Del Río, J., Frechilla, D., & Pérez-Mediavilla, A. (2011). Enhanced expression of the voltage-dependent anion channel 1 (VDAC1) in Alzheimer’s disease transgenic mice: An insight into the pathogenic effects of amyloid-β. Journal of Alzheimer’s disease: JAD, 23(2), 195–206. https://doi.org/10.3233/jad-2010-100966.
Cui, L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., & Krainc, D. (2006). Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127(1), 59–69. https://doi.org/10.1016/j.cell.2006.09.015.
Cuitino, L., Godoy, J. A., Farías, G. G., Couve, A., Bonansco, C., Fuenzalida, M., et al. (2010). Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 30(25), 8411–8420. https://doi.org/10.1523/jneurosci.5736-09.2010.
Cuturic, M., Abramson, R. K., Vallini, D., Frank, E. M., & Shamsnia, M. (2009). Sleep patterns in patients with Huntington’s disease and their unaffected first-degree relatives: A brief report. Behavioral Sleep Medicine, 7(4), 245–254. https://doi.org/10.1080/15402000903190215.
Czeisler, C. A., Dumont, M., Duffy, J. F., Steinberg, J. D., Richardson, G. S., Brown, E. N., et al. (1992). Association of sleep-wake habits in older people with changes in output of circadian pacemaker. Lancet (London, England), 340(8825), 933–936.
d’Abramo, C., Massone, S., Zingg, J.-M., Pizzuti, A., Marambaud, P., Dalla Piccola, B., et al. (2005). Role of peroxisome proliferator-activated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death. The Biochemical Journal, 391(Pt 3), 693–698. https://doi.org/10.1042/bj20050560.
Damiano, M., Diguet, E., Malgorn, C., D’Aurelio, M., Galvan, L., Petit, F., et al. (2013). A role of mitochondrial complex II defects in genetic models of Huntington’s disease expressing N-terminal fragments of mutant huntingtin. Human Molecular Genetics, 22(19), 3869–3882. https://doi.org/10.1093/hmg/ddt242.
Damiano, M., Galvan, L., Déglon, N., & Brouillet, E. (2010). Mitochondria in Huntington’s disease. Biochimica et Biophysica Acta, 1802(1), 52–61. https://doi.org/10.1016/j.bbadis.2009.07.012.
Daynes, R. A., & Jones, D. C. (2002). Emerging roles of PPARs in inflammation and immunity. Nature Reviews Immunology, 2(10), 748–759. https://doi.org/10.1038/nri912.
De Cruz, S., Espiritu, J. R. D., Zeidler, M., & Wang, T. S. (2012). Sleep disorders in chronic liver disease. Seminars in Respiratory and Critical Care Medicine, 33(1), 26–35. https://doi.org/10.1055/s-0032-1301732.
de la Monte, S. M., & Wands, J. R. (2006). Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer’s disease. Journal of Alzheimer’s disease: JAD, 9(2), 167–181.
Demetrius, L. A., & Driver, J. (2013). Alzheimer’s as a metabolic disease. Biogerontology, 14(6), 641–649. https://doi.org/10.1007/s10522-013-9479-7.
Demetrius, L. A., Magistretti, P. J., & Pellerin, L. (2014). Alzheimer’s disease: The amyloid hypothesis and the Inverse Warburg effect. Frontiers in Physiology, 5, 522. https://doi.org/10.3389/fphys.2014.00522.
Demetrius, L. A., & Simon, D. K. (2012). An inverse-Warburg effect and the origin of Alzheimer’s disease. Biogerontology, 13(6), 583–594. https://doi.org/10.1007/s10522-012-9403-6.
Devos, D., Kroumova, M., Bordet, R., Vodougnon, H., Guieu, J. D., Libersa, C., et al. (2003). Heart rate variability and Parkinson’s disease severity. Journal of Neural Transmission (Vienna, Austria: 1996), 110(9), 997–1011. https://doi.org/10.1007/s00702-003-0016-8.
Dickins, E. M., & Salinas, P. C. (2013). Wnts in action: From synapse formation to synaptic maintenance. Frontiers in Cellular Neuroscience, 7, 162. https://doi.org/10.3389/fncel.2013.00162.
Dienel, G. A. (2012). Brain lactate metabolism: The discoveries and the controversies. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 32(7), 1107–1138. https://doi.org/10.1038/jcbfm.2011.175.
DiNuzzo, M., Maraviglia, B., & Giove, F. (2011). Why does the brain (not) have glycogen? BioEssays: News and Reviews in Molecular, Cellular and Developmental Biology, 33(5), 319–326. https://doi.org/10.1002/bies.201000151.
Djouadi, F., Lecarpentier, Y., Hébert, J.-L., Charron, P., Bastin, J., & Coirault, C. (2009). A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy. Cardiovascular Research, 84(1), 83–90. https://doi.org/10.1093/cvr/cvp183.
Dong, H., Yuede, C. M., Yoo, H.-S., Martin, M. V., Deal, C., Mace, A. G., et al. (2008). Corticosterone and related receptor expression are associated with increased beta-amyloid plaques in isolated Tg2576 mice. Neuroscience, 155(1), 154–163. https://doi.org/10.1016/j.neuroscience.2008.05.017.
Drew, P. D., Xu, J., & Racke, M. K. (2008). PPAR-gamma: Therapeutic potential for multiple sclerosis. PPAR research, 2008, 627463. https://doi.org/10.1155/2008/627463.
Dubocovich, M. L. (2007). Melatonin receptors: Role on sleep and circadian rhythm regulation. Sleep Medicine, 8(Suppl 3), 34–42. https://doi.org/10.1016/j.sleep.2007.10.007.
Duffield, G. E., Best, J. D., Meurers, B. H., Bittner, A., Loros, J. J., & Dunlap, J. C. (2002). Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Current biology: CB, 12(7), 551–557.
Duffy, J. F., Zeitzer, J. M., Rimmer, D. W., Klerman, E. B., Dijk, D.-J., & Czeisler, C. A. (2002). Peak of circadian melatonin rhythm occurs later within the sleep of older subjects. American journal of physiology. Endocrinology and metabolism, 282(2), E297–E303. https://doi.org/10.1152/ajpendo.00268.2001.
Duggan, S. P., & McCarthy, J. V. (2016). Beyond γ-secretase activity: The multifunctional nature of presenilins in cell signalling pathways. Cellular Signalling, 28(1), 1–11. https://doi.org/10.1016/j.cellsig.2015.10.006.
Dun, Y., Li, G., Yang, Y., Xiong, Z., Feng, M., Wang, M., et al. (2012). Inhibition of the canonical Wnt pathway by Dickkopf-1 contributes to the neurodegeneration in 6-OHDA-lesioned rats. Neuroscience Letters, 525(2), 83–88. https://doi.org/10.1016/j.neulet.2012.07.030.
Duncan, M. J., Smith, J. T., Franklin, K. M., Beckett, T. L., Murphy, M. P., St Clair, D. K., et al. (2012). Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer’s disease. Experimental Neurology, 236(2), 249–258. https://doi.org/10.1016/j.expneurol.2012.05.011.
Dunn, L., Allen, G. F., Mamais, A., Ling, H., Li, A., Duberley, K. E., et al. (2014). Dysregulation of glucose metabolism is an early event in sporadic Parkinson’s disease. Neurobiology of Aging, 35(5), 1111–1115. https://doi.org/10.1016/j.neurobiolaging.2013.11.001.
Dupont, P., Besson, M.-T., Devaux, J., & Liévens, J.-C. (2012). Reducing canonical Wingless/Wnt signaling pathway confers protection against mutant Huntingtin toxicity in Drosophila. Neurobiology of Disease, 47(2), 237–247. https://doi.org/10.1016/j.nbd.2012.04.007.
Dupuis, L., Pradat, P.-F., Ludolph, A. C., & Loeffler, J.-P. (2011). Energy metabolism in amyotrophic lateral sclerosis. The Lancet Neurology, 10(1), 75–82. https://doi.org/10.1016/s1474-4422(10)70224-6.
Edison, P., Ahmed, I., Fan, Z., Hinz, R., Gelosa, G., Ray Chaudhuri, K., et al. (2013). Microglia, amyloid, and glucose metabolism in Parkinson’s disease with and without dementia. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 38(6), 938–949. https://doi.org/10.1038/npp.2012.255.
Ehrnhoefer, D. E., Wong, B. K. Y., & Hayden, M. R. (2011). Convergent pathogenic pathways in Alzheimer’s and Huntington’s diseases: Shared targets for drug development. Nature Reviews Drug Discovery, 10(11), 853–867. https://doi.org/10.1038/nrd3556.
Elbrecht, A., Chen, Y., Cullinan, C. A., Hayes, N., Leibowitz, M. D., Moller, D. E., et al. (1996). Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors gamma 1 and gamma 2. Biochemical and Biophysical Research Communications, 224(2), 431–437.
El-Sahar, A. E., Safar, M. M., Zaki, H. F., Attia, A. S., & Ain-Shoka, A. A. (2015). Neuroprotective effects of pioglitazone against transient cerebral ischemic reperfusion injury in diabetic rats: Modulation of antioxidant, anti-inflammatory, and anti-apoptotic biomarkers. Pharmacological reports: PR, 67(5), 901–906. https://doi.org/10.1016/j.pharep.2015.03.018.
Escribano, L., Simón, A.-M., Gimeno, E., Cuadrado-Tejedor, M., López de Maturana, R., García-Osta, A., et al. (2010). Rosiglitazone rescues memory impairment in Alzheimer’s transgenic mice: Mechanisms involving a reduced amyloid and tau pathology. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 35(7), 1593–1604. https://doi.org/10.1038/npp.2010.32.
Esmaeili, M. A., Yadav, S., Gupta, R. K., Waggoner, G. R., Deloach, A., Calingasan, N. Y., et al. (2016). Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo. Human Molecular Genetics, 25(2), 317–327. https://doi.org/10.1093/hmg/ddv477.
Essers, M. A. G., de Vries-Smits, L. M. M., Barker, N., Polderman, P. E., Burgering, B. M. T., & Korswagen, H. C. (2005). Functional interaction between beta-catenin and FOXO in oxidative stress signaling. Science (New York, N.Y.), 308(5725), 1181–1184. https://doi.org/10.1126/science.1109083.
Evans, J. A., & Davidson, A. J. (2013). Health consequences of circadian disruption in humans and animal models. Progress in Molecular Biology and Translational Science, 119, 283–323. https://doi.org/10.1016/b978-0-12-396971-2.00010-5.
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A. M., Saladin, R., et al. (1997). The organization, promoter analysis, and expression of the human PPARgamma gene. The Journal of biological Chemistry, 272(30), 18779–18789.
Farajnia, S., Michel, S., Deboer, T., Vander leest, H. T., Houben, T., Rohling, J. H. T., et al. (2012). Evidence for neuronal desynchrony in the aged suprachiasmatic nucleus clock. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 32(17), 5891–5899. https://doi.org/10.1523/jneurosci.0469-12.2012.
Farshbaf, M. J., Ghaedi, K., Shirani, M., & Nasr-Esfahani, M. H. (2014). Peroxisome proliferator activated receptor gamma (PPARγ) as a therapeutic target for improvement of cognitive performance in Fragile-X. Medical Hypotheses, 82(3), 291–294. https://doi.org/10.1016/j.mehy.2013.12.012.
Feng, Z., Qin, C., Chang, Y., & Zhang, J. (2006). Early melatonin supplementation alleviates oxidative stress in a transgenic mouse model of Alzheimer’s disease. Free Radical Biology and Medicine, 40(1), 101–109. https://doi.org/10.1016/j.freeradbiomed.2005.08.014.
Fernández de Mattos, S., Essafi, A., Soeiro, I., Pietersen, A. M., Birkenkamp, K. U., Edwards, C. S., et al. (2004). FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism. Molecular and Cellular Biology, 24(22), 10058–10071. https://doi.org/10.1128/mcb.24.22.10058-10071.2004.
Finkbeiner, S. (2011). Huntington’s disease. Cold Spring Harbor Perspectives in Biology, 3(6), a007476. https://doi.org/10.1101/cshperspect.a007476.
Fontaine, C., Dubois, G., Duguay, Y., Helledie, T., Vu-Dac, N., Gervois, P., et al. (2003). The orphan nuclear receptor Rev-Erbalpha is a peroxisome proliferator-activated receptor (PPAR) gamma target gene and promotes PPARgamma-induced adipocyte differentiation. The Journal of biological chemistry, 278(39), 37672–37680. https://doi.org/10.1074/jbc.m304664200.
Franco-Iborra, S., Vila, M., & Perier, C. (2016). The Parkinson disease mitochondrial hypothesis: Where are we at? The Neuroscientist: A Review Journal Bringing Neurobiology, Neurology and Psychiatry, 22(3), 266–277. https://doi.org/10.1177/1073858415574600.
Fuenzalida, K., Quintanilla, R., Ramos, P., Piderit, D., Fuentealba, R. A., Martinez, G., et al. (2007). Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. The Journal of biological chemistry, 282(51), 37006–37015. https://doi.org/10.1074/jbc.m700447200.
Galano, A., Tan, D. X., & Reiter, R. J. (2013). On the free radical scavenging activities of melatonin’s metabolites, AFMK and AMK. Journal of Pineal Research, 54(3), 245–257. https://doi.org/10.1111/jpi.12010.
Galea, E., Heneka, M. T., Dello Russo, C., & Feinstein, D. L. (2003). Intrinsic regulation of brain inflammatory responses. Cellular and Molecular Neurobiology, 23(4–5), 625–635.
Gao, J., Huang, X., Park, Y., Hollenbeck, A., Blair, A., Schatzkin, A., et al. (2011). Daytime napping, nighttime sleeping, and Parkinson disease. American Journal of Epidemiology, 173(9), 1032–1038. https://doi.org/10.1093/aje/kwq478.
García-Bueno, B., Caso, J. R., Pérez-Nievas, B. G., Lorenzo, P., & Leza, J. C. (2007). Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology, 32(6), 1251–1260. https://doi.org/10.1038/sj.npp.1301252.
García-Bueno, B., Madrigal, J. L. M., Lizasoain, I., Moro, M. A., Lorenzo, P., & Leza, J. C. (2005). The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. Psychopharmacology (Berl), 180(3), 513–522. https://doi.org/10.1007/s00213-005-2195-5.
Garcia-Gras, E., Lombardi, R., Giocondo, M. J., Willerson, J. T., Schneider, M. D., Khoury, D. S., et al. (2006). Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. The Journal of Clinical Investigation, 116(7), 2012–2021. https://doi.org/10.1172/jci27751.
García-Martínez, R., & Córdoba, J. (2011). Acute-on-chronic liver failure: the brain. Current Opinion in Critical Care, 17(2), 177–183. https://doi.org/10.1097/mcc.0b013e328344b37e.
García-Mesa, Y., Giménez-Llort, L., López, L. C., Venegas, C., Cristòfol, R., Escames, G., et al. (2012). Melatonin plus physical exercise are highly neuroprotective in the 3xTg-AD mouse. Neurobiology of Aging, 33(6), 1124.e13-29. https://doi.org/10.1016/j.neurobiolaging.2011.11.016.
Gargiulo Monachelli, G., Meyer, M., Rodríguez, G. E., Garay, L. I., Sica, R. E. P., De Nicola, A. F., et al. (2011). Endogenous progesterone is associated to amyotrophic lateral sclerosis prognostic factors. Acta Neurologica Scandinavica, 123(1), 60–67. https://doi.org/10.1111/j.1600-0404.2010.01385.x.
Gargiulo-Monachelli, G. M., Sivori, M., Meyer, M., Sica, R. E. P., De Nicola, A. F., & Gonzalez-Deniselle, M. C. (2014). Circulating gonadal and adrenal steroids in amyotrophic lateral sclerosis: Possible markers of susceptibility and outcome. Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, 46(6), 433–439. https://doi.org/10.1055/s-0034-1371891.
Gekakis, N., Staknis, D., Nguyen, H. B., Davis, F. C., Wilsbacher, L. D., King, D. P., et al. (1998). Role of the CLOCK protein in the mammalian circadian mechanism. Science (New York, N.Y.), 280(5369), 1564–1569.
Ghosh, P. S., Hupertz, V., & Ghosh, D. (2012). Neurological complications following pediatric liver transplant. Journal of Pediatric Gastroenterology and Nutrition, 54(4), 540–546. https://doi.org/10.1097/mpg.0b013e3182407de3.
Ghosh, S., Patel, N., Rahn, D., McAllister, J., Sadeghi, S., Horwitz, G., et al. (2007). The thiazolidinedione pioglitazone alters mitochondrial function in human neuron-like cells. Molecular Pharmacology, 71(6), 1695–1702. https://doi.org/10.1124/mol.106.033845.
Gibson, E. M., Wang, C., Tjho, S., Khattar, N., & Kriegsfeld, L. J. (2010). Experimental “jet lag” inhibits adult neurogenesis and produces long-term cognitive deficits in female hamsters. PLoS ONE, 5(12), e15267. https://doi.org/10.1371/journal.pone.0015267.
Giese, K. P. (2009). GSK-3: A key player in neurodegeneration and memory. IUBMB Life, 61(5), 516–521. https://doi.org/10.1002/iub.187.
Gines, S., Ivanova, E., Seong, I.-S., Saura, C. A., & MacDonald, M. E. (2003). Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington’s disease knock-in striatal cells. The Journal of biological chemistry, 278(50), 50514–50522. https://doi.org/10.1074/jbc.m309348200.
Godin, J. D., Poizat, G., Hickey, M. A., Maschat, F., & Humbert, S. (2010). Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington’s disease. The EMBO journal, 29(14), 2433–2445. https://doi.org/10.1038/emboj.2010.117.
Goldbeter, A. (1973). Patterns of spatiotemporal organization in an allosteric enzyme model. Proceedings of the National Academy of Sciences of the United States of America, 70(11), 3255–3259.
Goldbeter, A. (2002). Computational approaches to cellular rhythms. Nature, 420(6912), 238–245. https://doi.org/10.1038/nature01259.
Goodwin, B. C. (1965). Oscillatory behavior in enzymatic control processes. Advances in Enzyme Regulation, 3, 425–438.
Grandemange, S., Herzig, S., & Martinou, J.-C. (2009). Mitochondrial dynamics and cancer. Seminars in Cancer Biology, 19(1), 50–56. https://doi.org/10.1016/j.semcancer.2008.12.001.
Gravotta, L., Gavrila, A. M., Hood, S., & Amir, S. (2011). Global depletion of dopamine using intracerebroventricular 6-hydroxydopamine injection disrupts normal circadian wheel-running patterns and PERIOD2 expression in the rat forebrain. Journal of molecular neuroscience: MN, 45(2), 162–171. https://doi.org/10.1007/s12031-011-9520-8.
Green, K. N., Billings, L. M., Roozendaal, B., McGaugh, J. L., & LaFerla, F. M. (2006). Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer’s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 26(35), 9047–9056. https://doi.org/10.1523/jneurosci.2797-06.2006.
Green, C. B., Douris, N., Kojima, S., Strayer, C. A., Fogerty, J., Lourim, D., et al. (2007). Loss of Nocturnin, a circadian deadenylase, confers resistance to hepatic steatosis and diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America, 104(23), 9888–9893. https://doi.org/10.1073/pnas.0702448104.
Grinberg, L. T., Rueb, U., di Lorenzo Alho, A. T., & Heinsen, H. (2010). Brainstem pathology and non-motor symptoms in PD. Journal of the Neurological Sciences, 289(1–2), 81–88. https://doi.org/10.1016/j.jns.2009.08.021.
Guo, B., Chatterjee, S., Li, L., Kim, J. M., Lee, J., Yechoor, V. K., et al. (2012). The clock gene, brain and muscle Arnt-like 1, regulates adipogenesis via Wnt signaling pathway. FASEB Journal: official Publication of the Federation of American Societies for Experimental Biology, 26(8), 3453–3463. https://doi.org/10.1096/fj.12-205781.
Guven, C., Taskin, E., & Akcakaya, H. (2016). Melatonin prevents mitochondrial damage induced by doxorubicin in mouse fibroblasts through AMPK-PPAR gamma-dependent mechanisms. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research, 22, 438–446.
Häbig, K., Walter, M., Poths, S., Riess, O., & Bonin, M. (2008). RNA interference of LRRK2-microarray expression analysis of a Parkinson’s disease key player. Neurogenetics, 9(2), 83–94. https://doi.org/10.1007/s10048-007-0114-0.
Hahn, E. A., Wang, H.-X., Andel, R., & Fratiglioni, L. (2014). A change in sleep pattern may predict Alzheimer disease. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 22(11), 1262–1271. https://doi.org/10.1016/j.jagp.2013.04.015.
Halim, N. D., Mcfate, T., Mohyeldin, A., Okagaki, P., Korotchkina, L. G., Patel, M. S., et al. (2010). Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia, 58(10), 1168–1176. https://doi.org/10.1002/glia.20996.
Haramizu, S., Ota, N., Hase, T., & Murase, T. (2011). Aging-associated changes in physical performance and energy metabolism in the senescence-accelerated mouse. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 66(6), 646–655. https://doi.org/10.1093/gerona/glr037.
Hardin, P. E., Hall, J. C., & Rosbash, M. (1990). Feedback of the Drosophila period gene product on circadian cycling of its messenger RNA levels. Nature, 343(6258), 536–540. https://doi.org/10.1038/343536a0.
Harris, R. A., Tindale, L., & Cumming, R. C. (2014). Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease. Biogerontology, 15(6), 559–577. https://doi.org/10.1007/s10522-014-9534-z.
Harrison-Uy, S. J., & Pleasure, S. J. (2012). Wnt signaling and forebrain development. Cold Spring Harbor Perspectives in Biology, 4(7), a008094. https://doi.org/10.1101/cshperspect.a008094.
Hatfield, C. F., Herbert, J., van Someren, E. J. W., Hodges, J. R., & Hastings, M. H. (2004). Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer’s dementia. Brain: A Journal of Neurology, 127, 1061–1074. https://doi.org/10.1093/brain/awh129.
He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., et al. (1998). Identification of c-MYC as a target of the APC pathway. Science (New York, N.Y.), 281(5382), 1509–1512.
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Dewachter, I., Walter, J., Klockgether, T., et al. (2005). Focal glial activation coincides with increased BACE1 activation and precedes amyloid plaque deposition in APP[V717I] transgenic mice. Journal of Neuroinflammation, 2, 22. https://doi.org/10.1186/1742-2094-2-22.
Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J. (2014). The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cellular Signalling, 26(12), 2694–2701. https://doi.org/10.1016/j.cellsig.2014.08.019.
Herrero-Mendez, A., Almeida, A., Fernández, E., Maestre, C., Moncada, S., & Bolaños, J. P. (2009). The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nature Cell Biology, 11(6), 747–752. https://doi.org/10.1038/ncb1881.
Herskovits, A. Z., & Guarente, L. (2013). Sirtuin deacetylases in neurodegenerative diseases of aging. Cell Research, 23(6), 746–758. https://doi.org/10.1038/cr.2013.70.
Hirsch, E. C., Vyas, S., & Hunot, S. (2012). Neuroinflammation in Parkinson’s disease. Parkinsonism & Related Disorders, 18(Suppl 1), S210–S212. https://doi.org/10.1016/s1353-8020(11)70065-7.
Hoepken, H.-H., Gispert, S., Morales, B., Wingerter, O., Del Turco, D., Mülsch, A., et al. (2007). Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6. Neurobiology of Disease, 25(2), 401–411. https://doi.org/10.1016/j.nbd.2006.10.007.
Hofman, M. A. (2000). The human circadian clock and aging. Chronobiology International, 17(3), 245–259.
Hogenesch, J. B., Gu, Y. Z., Jain, S., & Bradfield, C. A. (1998). The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proceedings of the National Academy of Sciences of the United States of America, 95(10), 5474–5479.
Hood, S., Cassidy, P., Cossette, M.-P., Weigl, Y., Verwey, M., Robinson, B., et al. (2010). Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 30(42), 14046–14058. https://doi.org/10.1523/jneurosci.2128-10.2010.
Hoogeboom, D., Essers, M. A. G., Polderman, P. E., Voets, E., Smits, L. M. M., & Burgering, B. M. T. (2008). Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity. The Journal of biological chemistry, 283(14), 9224–9230. https://doi.org/10.1074/jbc.m706638200.
Hooper, C., Killick, R., & Lovestone, S. (2008). The GSK3 hypothesis of Alzheimer’s disease. Journal of Neurochemistry, 104(6), 1433–1439. https://doi.org/10.1111/j.1471-4159.2007.05194.x.
Hoppe, J. B., Frozza, R. L., Horn, A. P., Comiran, R. A., Bernardi, A., Campos, M. M., et al. (2010). Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: Involvement of GSK-3beta, tau and neuroinflammation. Journal of Pineal Research, 48(3), 230–238. https://doi.org/10.1111/j.1600-079x.2010.00747.x.
Huang, Y., Potter, R., Sigurdson, W., Santacruz, A., Shih, S., Ju, Y.-E., et al. (2012). Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system. Archives of Neurology, 69(1), 51–58. https://doi.org/10.1001/archneurol.2011.235.
Hult, S., Schultz, K., Soylu, R., & Petersén, A. (2010). Hypothalamic and neuroendocrine changes in Huntington’s disease. Current Drug Targets, 11(10), 1237–1249.
Humbert, S., Bryson, E. A., Cordelières, F. P., Connors, N. C., Datta, S. R., Finkbeiner, S., et al. (2002). The IGF-1/Akt pathway is neuroprotective in Huntington’s disease and involves Huntingtin phosphorylation by Akt. Developmental Cell, 2(6), 831–837.
Hunt, T. K., Aslam, R. S., Beckert, S., Wagner, S., Ghani, Q. P., Hussain, M. Z., et al. (2007). Aerobically derived lactate stimulates revascularization and tissue repair via redox mechanisms. Antioxidants & Redox Signaling, 9(8), 1115–1124. https://doi.org/10.1089/ars.2007.1674.
Hur, E.-M., & Zhou, F.-Q. (2010). GSK3 signalling in neural development. Nature Reviews Neuroscience, 11(8), 539–551. https://doi.org/10.1038/nrn2870.
Ille, F., & Sommer, L. (2005). Wnt signaling: Multiple functions in neural development. Cellular and molecular life sciences: CMLS, 62(10), 1100–1108. https://doi.org/10.1007/s00018-005-4552-2.
Imbesi, M., Yildiz, S., Dirim Arslan, A., Sharma, R., Manev, H., & Uz, T. (2009). Dopamine receptor-mediated regulation of neuronal “clock” gene expression. Neuroscience, 158(2), 537–544. https://doi.org/10.1016/j.neuroscience.2008.10.044.
Inestrosa, N. C., & Arenas, E. (2010). Emerging roles of Wnts in the adult nervous system. Nature Reviews Neuroscience, 11(2), 77–86. https://doi.org/10.1038/nrn2755.
Inestrosa, N. C., Montecinos-Oliva, C., & Fuenzalida, M. (2012). Wnt signaling: role in Alzheimer disease and schizophrenia. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 7(4), 788–807. https://doi.org/10.1007/s11481-012-9417-5.
Inestrosa, N. C., & Varela-Nallar, L. (2014). Wnt signaling in the nervous system and in Alzheimer’s disease. Journal of Molecular Cell Biology, 6(1), 64–74. https://doi.org/10.1093/jmcb/mjt051.
Islam, M. T. (2017). Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders. Neurological Research, 39(1), 73–82. https://doi.org/10.1080/01616412.2016.1251711.
Jakoby, P., Schmidt, E., Ruminot, I., Gutiérrez, R., Barros, L. F., & Deitmer, J. W. (2014). Higher transport and metabolism of glucose in astrocytes compared with neurons: A multiphoton study of hippocampal and cerebellar tissue slices. Cerebral Cortex (New York, N.Y.: 1991), 24(1), 222–231. https://doi.org/10.1093/cercor/bhs309.
Janich, P., Pascual, G., Merlos-Suárez, A., Batlle, E., Ripperger, J., Albrecht, U., et al. (2011). The circadian molecular clock creates epidermal stem cell heterogeneity. Nature, 480(7376), 209–214. https://doi.org/10.1038/nature10649.
Johri, A., & Beal, M. F. (2012). Mitochondrial dysfunction in neurodegenerative diseases. The Journal of Pharmacology and Experimental Therapeutics, 342(3), 619–630. https://doi.org/10.1124/jpet.112.192138.
Johri, A., Starkov, A. A., Chandra, A., Hennessey, T., Sharma, A., Orobello, S., et al. (2011). Truncated peroxisome proliferator-activated receptor-γ coactivator 1α splice variant is severely altered in Huntington’s disease. Neuro-Degenerative Diseases, 8(6), 496–503. https://doi.org/10.1159/000327910.
Joshi, P. R., Wu, N.-P., André, V. M., Cummings, D. M., Cepeda, C., Joyce, J. A., et al. (2009). Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29(8), 2414–2427. https://doi.org/10.1523/jneurosci.5687-08.2009.
Ju, Y.-E. S., Lucey, B. P., & Holtzman, D. M. (2014). Sleep and Alzheimer disease pathology—A bidirectional relationship. Nature Reviews. Neurology, 10(2), 115–119. https://doi.org/10.1038/nrneurol.2013.269.
Jucker, M., & Walker, L. C. (2011). Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Annals of Neurology, 70(4), 532–540. https://doi.org/10.1002/ana.22615.
Kalliolia, E., Silajdžić, E., Nambron, R., Hill, N. R., Doshi, A., Frost, C., et al. (2014). Plasma melatonin is reduced in Huntington’s disease. Movement Disorders: Official Journal of the Movement Disorder Society, 29(12), 1511–1515. https://doi.org/10.1002/mds.26003.
Kalman, B. A., & Grahn, R. E. (2004). Measuring salivary cortisol in the behavioral neuroscience laboratory. Journal of Undergraduate Neuroscience Education: JUNE: A Publication of FUN, Faculty for Undergraduate Neuroscience, 2(2), A41–A49.
Kalonia, H., Kumar, P., & Kumar, A. (2011). Attenuation of proinflammatory cytokines and apoptotic process by verapamil and diltiazem against quinolinic acid induced Huntington like alterations in rats. Brain Research, 1372, 115–126. https://doi.org/10.1016/j.brainres.2010.11.060.
Kang, J.-E., Lim, M. M., Bateman, R. J., Lee, J. J., Smyth, L. P., Cirrito, J. R., et al. (2009). Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science (New York, N.Y.), 326(5955), 1005–1007. https://doi.org/10.1126/science.1180962.
Kapadia, R., Yi, J.-H., & Vemuganti, R. (2008). Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Frontiers in Bioscience: A Journal and Virtual Library, 13, 1813–1826.
Kato, H., Tanaka, G., Masuda, S., Ogasawara, J., Sakurai, T., Kizaki, T., et al. (2015). Melatonin promotes adipogenesis and mitochondrial biogenesis in 3T3-L1 preadipocytes. Journal of Pineal Research, 59(2), 267–275. https://doi.org/10.1111/jpi.12259.
Kaur, S. J., McKeown, S. R., & Rashid, S. (2016). Mutant SOD1 mediated pathogenesis of amyotrophic lateral sclerosis. Gene, 577(2), 109–118. https://doi.org/10.1016/j.gene.2015.11.049.
Kawano, Y., & Kypta, R. (2003). Secreted antagonists of the Wnt signalling pathway. Journal of Cell Science, 116(Pt 13), 2627–2634. https://doi.org/10.1242/jcs.00623.
Kiaei, M. (2008). Peroxisome proliferator-activated receptor-gamma in amyotrophic lateral sclerosis and Huntington’s disease. PPAR Research, 2008, 418765. https://doi.org/10.1155/2008/418765.
Kim, J., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007). Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Molecular and Cellular Biology, 27(21), 7381–7393. https://doi.org/10.1128/mcb.00440-07.
Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015). The role of oxidative stress in neurodegenerative diseases. Experimental Neurobiology, 24(4), 325–340. https://doi.org/10.5607/en.2015.24.4.325.
Kim, E. J., Kwon, K. J., Park, J. Y., Lee, S. H., Moon, C. H., & Baik, E. J. (2002). Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: Associated with iNOS and COX-2. Brain Research, 941(1–2), 1–10.
Kim, W.-Y., & Snider, W. D. (2011). Functions of GSK-3 signaling in development of the nervous system. Frontiers in Molecular Neuroscience, 4, 44. https://doi.org/10.3389/fnmol.2011.00044.
Ko, C. H., & Takahashi, J. S. (2006). Molecular components of the mammalian circadian clock. Human Molecular Genetics, 15(2), 271–277. https://doi.org/10.1093/hmg/ddl207.
Kondepudi, D., & Prigogine, I. (1999). Modern thermodynamics from heat engines to dissipative structures. New York: Willey.
Kondratova, A. A., & Kondratov, R. V. (2012). The circadian clock and pathology of the ageing brain. Nature Reviews Neuroscience, 13(5), 325–335. https://doi.org/10.1038/nrn3208.
Körner, S., Hendricks, M., Kollewe, K., Zapf, A., Dengler, R., Silani, V., et al. (2013). Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): Impact on quality of life and therapeutic options. BMC neurology, 13, 84. https://doi.org/10.1186/1471-2377-13-84.
Korvala, J., Jüppner, H., Mäkitie, O., Sochett, E., Schnabel, D., Mora, S., et al. (2012). Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Medical Genetics, 13, 26. https://doi.org/10.1186/1471-2350-13-26.
Kott, J., Leach, G., & Yan, L. (2012). Direction-dependent effects of chronic “jet-lag” on hippocampal neurogenesis. Neuroscience Letters, 515(2), 177–180. https://doi.org/10.1016/j.neulet.2012.03.048.
Krishnan, N., Davis, A. J., & Giebultowicz, J. M. (2008). Circadian regulation of response to oxidative stress in Drosophila melanogaster. Biochemical and Biophysical Research Communications, 374(2), 299–303. https://doi.org/10.1016/j.bbrc.2008.07.011.
Krishnan, N., Kretzschmar, D., Rakshit, K., Chow, E., & Giebultowicz, J. M. (2009). The circadian clock gene period extends healthspan in aging Drosophila melanogaster. Aging, 1(11), 937–948. https://doi.org/10.18632/aging.100103.
Kudo, T., Schroeder, A., Loh, D. H., Kuljis, D., Jordan, M. C., Roos, K. P., et al. (2011). Dysfunctions in circadian behavior and physiology in mouse models of Huntington’s disease. Experimental Neurology, 228(1), 80–90. https://doi.org/10.1016/j.expneurol.2010.12.011.
Kuljis, D., Schroeder, A. M., Kudo, T., Loh, D. H., Willison, D. L., & Colwell, C. S. (2012). Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington’s disease. Minerva Pneumologica, 51(3), 93–106.
L’episcopo, F., Serapide, M. F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., et al. (2011). A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection. Molecular Neurodegeneration, 6, 49. https://doi.org/10.1186/1750-1326-6-49.
L’Episcopo, F., Tirolo, C., Testa, N., Caniglia, S., Morale, M. C., Deleidi, M., et al. (2012). Plasticity of subventricular zone neuroprogenitors in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse model of Parkinson’s disease involves cross talk between inflammatory and Wnt/β-catenin signaling pathways: functional consequences for neuroprotection and repair. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 32(6), 2062–2085. https://doi.org/10.1523/jneurosci.5259-11.2012.
Landreth, G., Jiang, Q., Mandrekar, S., & Heneka, M. (2008). PPARgamma agonists as therapeutics for the treatment of Alzheimer’s disease. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 5(3), 481–489. https://doi.org/10.1016/j.nurt.2008.05.003.
Lauretti, E., Di Meco, A., Merali, S., & Praticò, D. (2017). Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson’s disease. Molecular Psychiatry, 22(2), 280–286. https://doi.org/10.1038/mp.2016.47.
Lazar, A. S., Panin, F., Goodman, A. O. G., Lazic, S. E., Lazar, Z. I., Mason, S. L., et al. (2015). Sleep deficits but no metabolic deficits in premanifest Huntington’s disease. Annals of Neurology, 78(4), 630–648. https://doi.org/10.1002/ana.24495.
LeBlanc, J., & Ducharme, M. B. (2005). Influence of personality traits on plasma levels of cortisol and cholesterol. Physiology & Behavior, 84(5), 677–680. https://doi.org/10.1016/j.physbeh.2005.02.020.
Lebreton, F., Cayzac, S., Pietropaolo, S., Jeantet, Y., & Cho, Y. H. (2015). Sleep physiology alterations precede plethoric phenotypic changes in R6/1 Huntington’s disease mice. PLoS ONE, 10(5), e0126972. https://doi.org/10.1371/journal.pone.0126972.
Lecarpentier, Y., Claes, V., Duthoit, G., & Hébert, J.-L. (2014). Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction. Frontiers in Physiology, 5, 429. https://doi.org/10.3389/fphys.2014.00429.
Lecarpentier, Y., Claes, V., & Hébert, J.-L. (2010). PPARs, cardiovascular metabolism, and function: Near- or far-from-equilibrium pathways. PPAR research. https://doi.org/10.1155/2010/783273.
Lecarpentier, Y., Claes, V., Vallée, A., & Hébert, J.-L. (2017a). Interactions between PPAR gamma and the canonical Wnt/beta-catenin pathway in type 2 diabetes and colon cancer. PPAR Research, 2017, 1–9. https://doi.org/10.1155/2017/5879090.
Lecarpentier, Y., Claes, V., Vallée, A., & Hébert, J.-L. (2017b). Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway. Clinical and Translational Medicine, 6(1), 14. https://doi.org/10.1186/s40169-017-0144-7.
Lecarpentier, Y., & Vallée, A. (2016). Opposite Interplay between PPAR gamma and canonical Wnt/Beta-catenin pathway in amyotrophic lateral sclerosis. Frontiers in Neurology, 7, 100. https://doi.org/10.3389/fneur.2016.00100.
Lee, I.-K. (2014). The role of pyruvate dehydrogenase kinase in diabetes and obesity. Diabetes & Metabolism Journal, 38(3), 181–186. https://doi.org/10.4093/dmj.2014.38.3.181.
Lee, M. W., Kim, D. S., Kim, H. R., Kim, H. J., Yang, J. M., Ryu, S., et al. (2012). Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells. Biochemical and Biophysical Research Communications, 417(1), 552–557. https://doi.org/10.1016/j.bbrc.2011.12.001.
Lee, T. H., Pastorino, L., & Lu, K. P. (2011). Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease. Expert Reviews in Molecular Medicine, 13, e21. https://doi.org/10.1017/s1462399411001906.
Leone, T. C., Lehman, J. J., Finck, B. N., Schaeffer, P. J., Wende, A. R., Boudina, S., et al. (2005). PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biology, 3(4), e101. https://doi.org/10.1371/journal.pbio.0030101.
Li, X.-H., Du, L.-L., Cheng, X.-S., Jiang, X., Zhang, Y., Lv, B.-L., et al. (2013). Glycation exacerbates the neuronal toxicity of β-amyloid. Cell Death and Disease, 4, e673. https://doi.org/10.1038/cddis.2013.180.
Li, H., Kang, T., Qi, B., Kong, L., Jiao, Y., Cao, Y., et al. (2016). Neuroprotective effects of ginseng protein on PI3K/Akt signaling pathway in the hippocampus of D-galactose/AlCl3 inducing rats model of Alzheimer’s disease. Journal of Ethnopharmacology, 179, 162–169. https://doi.org/10.1016/j.jep.2015.12.020.
Libro, R., Bramanti, P., & Mazzon, E. (2016). The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sciences, 158, 78–88. https://doi.org/10.1016/j.lfs.2016.06.024.
Lim, A. S. P., Kowgier, M., Yu, L., Buchman, A. S., & Bennett, D. A. (2013a). Sleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older persons. Sleep, 36(7), 1027–1032. https://doi.org/10.5665/sleep.2802.
Lim, A. S. P., Yu, L., Kowgier, M., Schneider, J. A., Buchman, A. S., & Bennett, D. A. (2013b). Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA neurology, 70(12), 1544–1551. https://doi.org/10.1001/jamaneurol.2013.4215.
Lin, F., Chen, Y., Li, X., Zhao, Q., & Tan, Z. (2013). Over-expression of circadian clock gene Bmal1 affects proliferation and the canonical Wnt pathway in NIH-3T3 cells. Cell Biochemistry and Function, 31(2), 166–172. https://doi.org/10.1002/cbf.2871.
Lin, J., Wu, P.-H., Tarr, P. T., Lindenberg, K. S., St-Pierre, J., Zhang, C.-Y., et al. (2004). Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell, 119(1), 121–135. https://doi.org/10.1016/j.cell.2004.09.013.
Liu, K., Li, F., Han, H., Chen, Y., Mao, Z., Luo, J., et al. (2016). Parkin regulates the activity of pyruvate kinase M2. The Journal of biological chemistry, 291(19), 10307–10317. https://doi.org/10.1074/jbc.m115.703066.
Liu, Y., Liu, F., Iqbal, K., Grundke-Iqbal, I., & Gong, C.-X. (2008). Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Letters, 582(2), 359–364. https://doi.org/10.1016/j.febslet.2007.12.035.
Liu, J., Wang, H., Zuo, Y., & Farmer, S. R. (2006). Functional interaction between peroxisome proliferator-activated receptor gamma and beta-catenin. Molecular and Cellular Biology, 26(15), 5827–5837. https://doi.org/10.1128/mcb.00441-06.
Lo Coco, D., Mattaliano, P., Spataro, R., Mattaliano, A., & La Bella, V. (2011). Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry, 82(8), 839–842. https://doi.org/10.1136/jnnp.2010.228007.
Loewenstein, R. J., Weingartner, H., Gillin, J. C., Kaye, W., Ebert, M., & Mendelson, W. B. (1982). Disturbances of sleep and cognitive functioning in patients with dementia. Neurobiology of Aging, 3(4), 371–377.
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., et al. (2002). Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Molecular Cell, 10(3), 457–468.
Lopes, C., Ribeiro, M., Duarte, A. I., Humbert, S., Saudou, F., Pereira de Almeida, L., et al. (2014). IGF-1 intranasal administration rescues Huntington’s disease phenotypes in YAC128 mice. Molecular Neurobiology, 49(3), 1126–1142. https://doi.org/10.1007/s12035-013-8585-5.
Lu, K. P. (2004). Pinning down cell signaling, cancer and Alzheimer’s disease. Trends in Biochemical Sciences, 29(4), 200–209. https://doi.org/10.1016/j.tibs.2004.02.002.
Lu, D., & Carson, D. A. (2010). Repression of beta-catenin signaling by PPAR gamma ligands. European Journal of Pharmacology, 636(1–3), 198–202. https://doi.org/10.1016/j.ejphar.2010.03.010.
Luna-Medina, R., Cortes-Canteli, M., Alonso, M., Santos, A., Martínez, A., & Perez-Castillo, A. (2005). Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. The Journal of biological chemistry, 280(22), 21453–21462. https://doi.org/10.1074/jbc.m414390200.
Luque-Contreras, D., Carvajal, K., Toral-Rios, D., Franco-Bocanegra, D., & Campos-Peña, V. (2014). Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer’s disease? Oxidative Medicine and Cellular Longevity, 2014, 497802. https://doi.org/10.1155/2014/497802.
Lv, L., Li, D., Zhao, D., Lin, R., Chu, Y., Zhang, H., et al. (2011). Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Molecular Cell, 42(6), 719–730. https://doi.org/10.1016/j.molcel.2011.04.025.
Maguire-Zeiss, K. A., & Federoff, H. J. (2010). Future directions for immune modulation in neurodegenerative disorders: Focus on Parkinson’s disease. Journal of Neural Transmission (Vienna, Austria: 1996), 117(8), 1019–1025. https://doi.org/10.1007/s00702-010-0431-6.
Manolopoulos, K. N., Klotz, L.-O., Korsten, P., Bornstein, S. R., & Barthel, A. (2010). Linking Alzheimer’s disease to insulin resistance: The FoxO response to oxidative stress. Molecular Psychiatry, 15(11), 1046–1052. https://doi.org/10.1038/mp.2010.17.
Marchetti, B., & Pluchino, S. (2013). Wnt your brain be inflamed? Yes, it Wnt! Trends in Molecular Medicine, 19(3), 144–156. https://doi.org/10.1016/j.molmed.2012.12.001.
Marpegan, L., Swanstrom, A. E., Chung, K., Simon, T., Haydon, P. G., Khan, S. K., et al. (2011). Circadian regulation of ATP release in astrocytes. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(23), 8342–8350. https://doi.org/10.1523/jneurosci.6537-10.2011.
Mattam, U., & Jagota, A. (2015). Daily rhythms of serotonin metabolism and the expression of clock genes in suprachiasmatic nucleus of rotenone-induced Parkinson’s disease male Wistar rat model and effect of melatonin administration. Biogerontology, 16(1), 109–123. https://doi.org/10.1007/s10522-014-9541-0.
Mauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J., & González-Gallego, J. (2013). A review of the molecular aspects of melatonin’s anti-inflammatory actions: Recent insights and new perspectives. Journal of Pineal Research, 54(1), 1–14. https://doi.org/10.1111/j.1600-079x.2012.01014.x.
Maywood, E. S., Fraenkel, E., McAllister, C. J., Wood, N., Reddy, A. B., Hastings, M. H., et al. (2010). Disruption of peripheral circadian timekeeping in a mouse model of Huntington’s disease and its restoration by temporally scheduled feeding. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 30(30), 10199–10204. https://doi.org/10.1523/jneurosci.1694-10.2010.
McEwen, B. S. (2000). The neurobiology of stress: From serendipity to clinical relevance. Brain Research, 886(1–2), 172–189.
McEwen, B. S., & Reagan, L. P. (2004). Glucose transporter expression in the central nervous system: Relationship to synaptic function. European Journal of Pharmacology, 490(1–3), 13–24. https://doi.org/10.1016/j.ejphar.2004.02.041.
Milakovic, T., & Johnson, G. V. W. (2005). Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant huntingtin. The Journal of biological chemistry, 280(35), 30773–30782. https://doi.org/10.1074/jbc.m504749200.
Miquel, E., Cassina, A., Martínez-Palma, L., Bolatto, C., Trías, E., Gandelman, M., et al. (2012). Modulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosis. PLoS ONE, 7(4), e34776. https://doi.org/10.1371/journal.pone.0034776.
Mizobuchi, M., Hineno, T., Kakimoto, Y., & Hiratani, K. (1993). Increase of plasma adrenocorticotrophin and cortisol in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated dogs. Brain Research, 612(1–2), 319–321.
Mochel, F., & Haller, R. G. (2011). Energy deficit in Huntington disease: Why it matters. The Journal of Clinical Investigation, 121(2), 493–499. https://doi.org/10.1172/jci45691.
Moldes, M., Zuo, Y., Morrison, R. F., Silva, D., Park, B.-H., Liu, J., et al. (2003). Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. The Biochemical Journal, 376(Pt 3), 607–613. https://doi.org/10.1042/bj20030426.
Mongrain, V., La Spada, F., Curie, T., & Franken, P. (2011). Sleep loss reduces the DNA-binding of BMAL1, CLOCK, and NPAS2 to specific clock genes in the mouse cerebral cortex. PLoS ONE, 6(10), e26622. https://doi.org/10.1371/journal.pone.0026622.
Morton, A. J., Wood, N. I., Hastings, M. H., Hurelbrink, C., Barker, R. A., & Maywood, E. S. (2005). Disintegration of the sleep-wake cycle and circadian timing in Huntington’s disease. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 25(1), 157–163. https://doi.org/10.1523/jneurosci.3842-04.2005.
Mosconi, L., Pupi, A., & De Leon, M. J. (2008). Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer’s disease. Annals of the New York Academy of Sciences, 1147, 180–195. https://doi.org/10.1196/annals.1427.007.
Musiek, E. S. (2015). Circadian clock disruption in neurodegenerative diseases: Cause and effect? Frontiers in Pharmacology, 6, 29. https://doi.org/10.3389/fphar.2015.00029.
Musiek, E. S., Lim, M. M., Yang, G., Bauer, A. Q., Qi, L., Lee, Y., et al. (2013). Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. The Journal of Clinical Investigation, 123(12), 5389–5400. https://doi.org/10.1172/jci70317.
Naia, L., Ferreira, I. L., Cunha-Oliveira, T., Duarte, A. I., Ribeiro, M., Rosenstock, T. R., et al. (2015). Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington’s Disease human lymphoblasts. Molecular Neurobiology, 51(1), 331–348. https://doi.org/10.1007/s12035-014-8735-4.
Nakatsu, Y., Matsunaga, Y., Yamamotoya, T., Ueda, K., Inoue, Y., Mori, K., et al. (2016). Physiological and pathogenic roles of prolyl isomerase Pin1 in metabolic regulations via multiple signal transduction pathway modulations. International Journal of Molecular Sciences, 17(9), 1495. https://doi.org/10.3390/ijms17091495.
Napoli, E., Wong, S., Hung, C., Ross-Inta, C., Bomdica, P., & Giulivi, C. (2013). Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington’s disease. Human Molecular Genetics, 22(5), 989–1004. https://doi.org/10.1093/hmg/dds503.
Nenov, M. N., Laezza, F., Haidacher, S. J., Zhao, Y., Sadygov, R. G., Starkey, J. M., et al. (2014). Cognitive enhancing treatment with a PPARγ agonist normalizes dentate granule cell presynaptic function in Tg2576 APP mice. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 34(3), 1028–1036. https://doi.org/10.1523/jneurosci.3413-13.2014.
Neves, A., Costalat, R., & Pellerin, L. (2012). Determinants of brain cell metabolic phenotypes and energy substrate utilization unraveled with a modeling approach. PLoS Computational Biology, 8(9), e1002686. https://doi.org/10.1371/journal.pcbi.1002686.
Newington, J. T., Pitts, A., Chien, A., Arseneault, R., Schubert, D., & Cumming, R. C. (2011). Amyloid beta resistance in nerve cell lines is mediated by the Warburg effect. PLoS ONE, 6(4), e19191. https://doi.org/10.1371/journal.pone.0019191.
Newington, J. T., Rappon, T., Albers, S., Wong, D. Y., Rylett, R. J., & Cumming, R. C. (2012). Overexpression of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase A in nerve cells confers resistance to amyloid β and other toxins by decreasing mitochondrial respiration and reactive oxygen species production. The Journal of biological chemistry, 287(44), 37245–37258. https://doi.org/10.1074/jbc.m112.366195.
Nicolakakis, N., & Hamel, E. (2010). The nuclear receptor PPARgamma as a therapeutic target for cerebrovascular and brain dysfunction in Alzheimer’s disease. Frontiers in Aging Neuroscience. https://doi.org/10.3389/fnagi.2010.00021.
Nicolis, G., & Prigogine, I. (1971). Fluctuations in nonequilibrium systems. Proceedings of the National Academy of Sciences of the United States of America, 68(9), 2102–2107.
Niida, A., Hiroko, T., Kasai, M., Furukawa, Y., Nakamura, Y., Suzuki, Y., et al. (2004). DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway. Oncogene, 23(52), 8520–8526. https://doi.org/10.1038/sj.onc.1207892.
Nir, Y., Staba, R. J., Andrillon, T., Vyazovskiy, V. V., Cirelli, C., Fried, I., et al. (2011). Regional slow waves and spindles in human sleep. Neuron, 70(1), 153–169. https://doi.org/10.1016/j.neuron.2011.02.043.
Obel, L. F., Müller, M. S., Walls, A. B., Sickmann, H. M., Bak, L. K., Waagepetersen, H. S., et al. (2012). Brain glycogen-new perspectives on its metabolic function and regulation at the subcellular level. Frontiers in Neuroenergetics, 4, 3. https://doi.org/10.3389/fnene.2012.00003.
Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., et al. (2009). Protection against cognitive deficits and markers of neurodegeneration by long-term oral administration of melatonin in a transgenic model of Alzheimer disease. Journal of Pineal Research, 47(1), 82–96. https://doi.org/10.1111/j.1600-079x.2009.00692.x.
Oliva, C. A., Vargas, J. Y., & Inestrosa, N. C. (2013). Wnts in adult brain: From synaptic plasticity to cognitive deficiencies. Frontiers in Cellular Neuroscience, 7, 224. https://doi.org/10.3389/fncel.2013.00224.
Orellana, A. M. M., Vasconcelos, A. R., Leite, J. A., de Sá Lima, L., Andreotti, D. Z., Munhoz, C. D., et al. (2015). Age-related neuroinflammation and changes in AKT-GSK-3β and WNT/β-CATENIN signaling in rat hippocampus. Aging, 7(12), 1094–1111. https://doi.org/10.18632/aging.100853.
Oz, G., Seaquist, E. R., Kumar, A., Criego, A. B., Benedict, L. E., Rao, J. P., et al. (2007). Human brain glycogen content and metabolism: implications on its role in brain energy metabolism. American Journal of Physiology. Endocrinology and metabolism, 292(3), E946–E951. https://doi.org/10.1152/ajpendo.00424.2006.
Palacino, J. J., Sagi, D., Goldberg, M. S., Krauss, S., Motz, C., Wacker, M., et al. (2004). Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. The Journal of Biological Chemistry, 279(18), 18614–18622. https://doi.org/10.1074/jbc.m401135200.
Panaccione, I., Napoletano, F., Forte, A. M., Kotzalidis, G. D., Del Casale, A., Rapinesi, C., et al. (2013). Neurodevelopment in schizophrenia: The role of the wnt pathways. Current Neuropharmacology, 11(5), 535–558. https://doi.org/10.2174/1570159x113119990037.
Parekh, P. K., Ozburn, A. R., & McClung, C. A. (2015). Circadian clock genes: effects on dopamine, reward and addiction. Alcohol (Fayetteville, N.Y.), 49(4), 341–349. https://doi.org/10.1016/j.alcohol.2014.09.034.
Parish, C. L., Castelo-Branco, G., Rawal, N., Tonnesen, J., Sorensen, A. T., Salto, C., et al. (2008). Wnt5a-treated midbrain neural stem cells improve dopamine cell replacement therapy in parkinsonian mice. The Journal of Clinical Investigation, 118(1), 149–160. https://doi.org/10.1172/jci32273.
Park, K. S., Lee, R. D., Kang, S.-K., Han, S. Y., Park, K. L., Yang, K. H., et al. (2004). Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway. Experimental Cell Research, 297(2), 424–433. https://doi.org/10.1016/j.yexcr.2004.03.034.
Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., et al. (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature, 437(7059), 759–763. https://doi.org/10.1038/nature03988.
Pate, K. T., Stringari, C., Sprowl-Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., et al. (2014). Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. The EMBO journal, 33(13), 1454–1473. https://doi.org/10.15252/embj.201488598.
Patel, A. B., Lai, J. C. K., Chowdhury, G. M. I., Hyder, F., Rothman, D. L., Shulman, R. G., et al. (2014). Direct evidence for activity-dependent glucose phosphorylation in neurons with implications for the astrocyte-to-neuron lactate shuttle. Proceedings of the National Academy of Sciences of the United States of America, 111(14), 5385–5390. https://doi.org/10.1073/pnas.1403576111.
Pellerin, L., & Magistretti, P. J. (2012). Sweet sixteen for ANLS. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 32(7), 1152–1166. https://doi.org/10.1038/jcbfm.2011.149.
Pesah, Y., Pham, T., Burgess, H., Middlebrooks, B., Verstreken, P., Zhou, Y., et al. (2004). Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development (Cambridge, England), 131(9), 2183–2194. https://doi.org/10.1242/dev.01095.
Peter-Derex, L., Yammine, P., Bastuji, H., & Croisile, B. (2015). Sleep and Alzheimer’s disease. Sleep Medicine Reviews, 19, 29–38. https://doi.org/10.1016/j.smrv.2014.03.007.
Pevet, P., & Challet, E. (2011). Melatonin: Both master clock output and internal time-giver in the circadian clocks network. Journal of Physiology, Paris, 105(4–6), 170–182. https://doi.org/10.1016/j.jphysparis.2011.07.001.
Piccini, P., Del Dotto, P., Pardini, C., D’Antonio, P., Rossi, G., & Bonuccelli, U. (1991). Diurnal worsening in Parkinson patients treated with levodopa. Rivista Di Neurologia, 61(6), 219–224.
Pinto, M., Nissanka, N., Peralta, S., Brambilla, R., Diaz, F., & Moraes, C. T. (2016). Pioglitazone ameliorates the phenotype of a novel Parkinson’s disease mouse model by reducing neuroinflammation. Molecular Neurodegeneration, 11, 25. https://doi.org/10.1186/s13024-016-0090-7.
Prigogine, I. (1986). Life and physics. New perspectives. Cell Biophysics, 9(1–2), 217–224. https://doi.org/10.1007/bf02797383.
Prigogine, I., & Nicolis, G. (1971). Biological order, structure and instabilities. Quarterly Reviews of Biophysics, 4(2), 107–148.
Prigogine, I., Nicolis, G., & Babloyantz, A. (1974). Nonequilibrium problems in biological phenomena. Annals of the New York Academy of Sciences, 231(1), 99–105.
Purro, S. A., Dickins, E. M., & Salinas, P. C. (2012). The secreted Wnt antagonist Dickkopf-1 is required for amyloid β-mediated synaptic loss. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 32(10), 3492–3498. https://doi.org/10.1523/jneurosci.4562-11.2012.
Quan, Q., Wang, J., Li, X., & Wang, Y. (2013). Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer’s disease. PLoS ONE, 8(3), e59155. https://doi.org/10.1371/journal.pone.0059155.
Rakshit, K., & Giebultowicz, J. M. (2013). Cryptochrome restores dampened circadian rhythms and promotes healthspan in aging Drosophila. Aging Cell, 12(5), 752–762. https://doi.org/10.1111/acel.12100.
Ramos, M., del Arco, A., Pardo, B., Martínez-Serrano, A., Martínez-Morales, J. R., Kobayashi, K., et al. (2003). Developmental changes in the Ca2+-regulated mitochondrial aspartate-glutamate carrier aralar1 in brain and prominent expression in the spinal cord. Brain Research. Developmental Brain Research, 143(1), 33–46.
Rani, N., Bharti, S., Bhatia, J., Nag, T. C., Ray, R., & Arya, D. S. (2016). Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation. Chemico-Biological Interactions, 250, 59–67. https://doi.org/10.1016/j.cbi.2016.03.015.
Rawal, N., Corti, O., Sacchetti, P., Ardilla-Osorio, H., Sehat, B., Brice, A., et al. (2009). Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling. Biochemical and Biophysical Research Communications, 388(3), 473–478. https://doi.org/10.1016/j.bbrc.2009.07.014.
Reppert, S. M., & Weaver, D. R. (2002). Coordination of circadian timing in mammals. Nature, 418(6901), 935–941. https://doi.org/10.1038/nature00965.
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010). Oxidative stress, inflammation, and cancer: How are they linked? Free Radical Biology and Medicine, 49(11), 1603–1616. https://doi.org/10.1016/j.freeradbiomed.2010.09.006.
Ricote, M., & Glass, C. K. (2007). PPARs and molecular mechanisms of transrepression. Biochimica et Biophysica Acta, 1771(8), 926–935. https://doi.org/10.1016/j.bbalip.2007.02.013.
Riggs, J. E. (1998). Aging, increasing genomic entropy, and neurodegenerative disease. Neurologic Clinics, 16(3), 757–770.
Roche, T. E., Baker, J. C., Yan, X., Hiromasa, Y., Gong, X., Peng, T., et al. (2001). Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Progress in Nucleic Acid Research and Molecular Biology, 70, 33–75.
Roh, J. H., Huang, Y., Bero, A. W., Kasten, T., Stewart, F. R., Bateman, R. J., et al. (2012). Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer’s disease pathology. Science Translational Medicine, 4(150), 150ra122. https://doi.org/10.1126/scitranslmed.3004291.
Rong, J. X., Klein, J.-L. D., Qiu, Y., Xie, M., Johnson, J. H., Waters, K. M., et al. (2011). Rosiglitazone induces mitochondrial biogenesis in differentiated murine 3T3-L1 and C3H/10T1/2 adipocytes. PPAR Research, 2011, 179454. https://doi.org/10.1155/2011/179454.
Rosales-Corral, S. A., Acuña-Castroviejo, D., Coto-Montes, A., Boga, J. A., Manchester, L. C., Fuentes-Broto, L., et al. (2012). Alzheimer’s disease: Pathological mechanisms and the beneficial role of melatonin. Journal of Pineal Research, 52(2), 167–202. https://doi.org/10.1111/j.1600-079x.2011.00937.x.
Rosi, M. C., Luccarini, I., Grossi, C., Fiorentini, A., Spillantini, M. G., Prisco, A., et al. (2010). Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. Journal of Neurochemistry, 112(6), 1539–1551. https://doi.org/10.1111/j.1471-4159.2009.06566.x.
Ryu, H., Rosas, H. D., Hersch, S. M., & Ferrante, R. J. (2005). The therapeutic role of creatine in Huntington’s disease. Pharmacology & Therapeutics, 108(2), 193–207. https://doi.org/10.1016/j.pharmthera.2005.04.008.
Sahar, S., & Sassone-Corsi, P. (2009). Metabolism and cancer: the circadian clock connection. Nature Reviews Cancer, 9(12), 886–896. https://doi.org/10.1038/nrc2747.
Salinas, P. C. (2012). Wnt signaling in the vertebrate central nervous system: From axon guidance to synaptic function. Cold Spring Harbor Perspectives in Biology. https://doi.org/10.1101/cshperspect.a008003.
Sameni, S., Syed, A., Marsh, J. L., & Digman, M. A. (2016). The phasor-FLIM fingerprints reveal shifts from OXPHOS to enhanced glycolysis in Huntington Disease. Scientific Reports, 6, 34755. https://doi.org/10.1038/srep34755.
Sancar, A., Lindsey-Boltz, L. A., Unsal-Kaçmaz, K., & Linn, S. (2004). Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annual Review of Biochemistry, 73, 39–85. https://doi.org/10.1146/annurev.biochem.73.011303.073723.
Sandler, S. (2006). Chemical and engineering thermodynamics (4th ed.). New-York: Wiely.
Schapira, A. H. V. (2008). Mitochondria in the aetiology and pathogenesis of Parkinson’s disease. The Lancet Neurology, 7(1), 97–109. https://doi.org/10.1016/s1474-4422(07)70327-7.
Schibler, U., & Sassone-Corsi, P. (2002). A web of circadian pacemakers. Cell, 111(7), 919–922.
Schmidt, M., Fernandez de Mattos, S., van der Horst, A., Klompmaker, R., Kops, G. J. P. L., Lam, E. W.-F., et al. (2002). Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Molecular and Cellular Biology, 22(22), 7842–7852.
Schnell, A., Chappuis, S., Schmutz, I., Brai, E., Ripperger, J. A., Schaad, O., et al. (2014). The nuclear receptor REV-ERBα regulates Fabp7 and modulates adult hippocampal neurogenesis. PLoS ONE, 9(6), e99883. https://doi.org/10.1371/journal.pone.0099883.
Schreiber, S. L. (1991). Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science (New York, N.Y.), 251(4991), 283–287.
Schubert, D. (2005). Glucose metabolism and Alzheimer’s disease. Ageing Research Reviews, 4(2), 240–257. https://doi.org/10.1016/j.arr.2005.02.003.
Schurr, A. (2014). Cerebral glycolysis: A century of persistent misunderstanding and misconception. Frontiers in Neuroscience, 8, 360. https://doi.org/10.3389/fnins.2014.00360.
Scuderi, C., Steardo, L., & Esposito, G. (2014). Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARγ involvement. Phytotherapy Research: PTR, 28(7), 1007–1013. https://doi.org/10.1002/ptr.5095.
Semënov, M. V., Zhang, X., & He, X. (2008). DKK1 antagonizes Wnt signaling without promotion of LRP6 internalization and degradation. The Journal of biological chemistry, 283(31), 21427–21432. https://doi.org/10.1074/jbc.m800014200.
Semenza, G. L. (2010). HIF-1: Upstream and downstream of cancer metabolism. Current Opinion in Genetics & Development, 20(1), 51–56. https://doi.org/10.1016/j.gde.2009.10.009.
Seong, I. S., Ivanova, E., Lee, J.-M., Choo, Y. S., Fossale, E., Anderson, M., et al. (2005). HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Human Molecular Genetics, 14(19), 2871–2880. https://doi.org/10.1093/hmg/ddi319.
Shang, Y. C., Chong, Z. Z., Hou, J., & Maiese, K. (2009). The forkhead transcription factor FOXO3a controls microglial inflammatory activation and eventual apoptotic injury through caspase 3. Current Neurovascular Research, 6(1), 20–31.
Shang, Y. C., Chong, Z. Z., Hou, J., & Maiese, K. (2010). Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress. Cellular Signalling, 22(9), 1317–1329. https://doi.org/10.1016/j.cellsig.2010.04.009.
Sharma, C., Pradeep, A., Wong, L., Rana, A., & Rana, B. (2004). Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway. The Journal of biological chemistry, 279(34), 35583–35594. https://doi.org/10.1074/jbc.m403143200.
Shimizu, T., Uchida, C., Shimizu, R., Motohashi, H., & Uchida, T. (2017). Prolyl isomerase Pin1 promotes proplatelet formation of megakaryocytes via tau. Biochemical and Biophysical Research Communications, 493(2), 946–951. https://doi.org/10.1016/j.bbrc.2017.09.115.
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., et al. (1999). The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proceedings of the National Academy of Sciences of the United States of America, 96(10), 5522–5527.
Siersbæk, M. S., Loft, A., Aagaard, M. M., Nielsen, R., Schmidt, S. F., Petrovic, N., et al. (2012). Genome-wide profiling of peroxisome proliferator-activated receptor γ in primary epididymal, inguinal, and brown adipocytes reveals depot-selective binding correlated with gene expression. Molecular and Cellular Biology, 32(17), 3452–3463. https://doi.org/10.1128/mcb.00526-12.
Simpson, I. A., Carruthers, A., & Vannucci, S. J. (2007). Supply and demand in cerebral energy metabolism: The role of nutrient transporters. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism, 27(11), 1766–1791. https://doi.org/10.1038/sj.jcbfm.9600521.
Skene, D. J., & Swaab, D. F. (2003). Melatonin rhythmicity: effect of age and Alzheimer’s disease. Experimental Gerontology, 38(1–2), 199–206.
Sochocka, M., Koutsouraki, E. S., Gasiorowski, K., & Leszek, J. (2013). Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer’s disease: A new approach to therapy. CNS & Neurological Disorders: Drug Targets, 12(6), 870–881.
Song, H., Moon, M., Choe, H. K., Han, D.-H., Jang, C., Kim, A., et al. (2015). Aβ-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer’s disease. Molecular Neurodegeneration. https://doi.org/10.1186/s13024-015-0007-x.
Soták, M., Sumová, A., & Pácha, J. (2014). Cross-talk between the circadian clock and the cell cycle in cancer. Annals of Medicine, 46(4), 221–232. https://doi.org/10.3109/07853890.2014.892296.
Soucek, T., Cumming, R., Dargusch, R., Maher, P., & Schubert, D. (2003). The regulation of glucose metabolism by HIF-1 mediates a neuroprotective response to amyloid beta peptide. Neuron, 39(1), 43–56.
Spataro, R., Volanti, P., Vitale, F., Meli, F., Colletti, T., Di Natale, A., et al. (2015). Plasma cortisol level in amyotrophic lateral sclerosis. Journal of the Neurological Sciences, 358(1–2), 282–286. https://doi.org/10.1016/j.jns.2015.09.011.
Stahl, M., Dijkers, P. F., Kops, G. J. P. L., Lens, S. M. A., Coffer, P. J., Burgering, B. M. T., et al. (2002). The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. Journal of Immunology (Baltimore, Md.: 1950), 168(10), 5024–5031.
Sterniczuk, R., Theou, O., Rusak, B., & Rockwood, K. (2013). Sleep disturbance is associated with incident dementia and mortality. Current Alzheimer Research, 10(7), 767–775.
Stobart, J. L., & Anderson, C. M. (2013). Multifunctional role of astrocytes as gatekeepers of neuronal energy supply. Frontiers in Cellular Neuroscience, 7, 38. https://doi.org/10.3389/fncel.2013.00038.
St-Pierre, J., Lin, J., Krauss, S., Tarr, P. T., Yang, R., Newgard, C. B., et al. (2003). Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. The Journal of biological chemistry, 278(29), 26597–26603. https://doi.org/10.1074/jbc.m301850200.
Struck, L. K., Rodnitzky, R. L., & Dobson, J. K. (1990). Circadian fluctuations of contrast sensitivity in Parkinson’s disease. Neurology, 40(3 Pt 1), 467–470.
Strum, J. C., Shehee, R., Virley, D., Richardson, J., Mattie, M., Selley, P., et al. (2007). Rosiglitazone induces mitochondrial biogenesis in mouse brain. Journal of Alzheimer’s disease: JAD, 11(1), 45–51.
Sun, Q., Chen, X., Ma, J., Peng, H., Wang, F., Zha, X., et al. (2011). Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proceedings of the National Academy of Sciences of the United States of America, 108(10), 4129–4134. https://doi.org/10.1073/pnas.1014769108.
Synofzik, M., Ronchi, D., Keskin, I., Basak, A. N., Wilhelm, C., Gobbi, C., et al. (2012). Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Human Molecular Genetics, 21(16), 3568–3574. https://doi.org/10.1093/hmg/dds188.
Szablewski, L. (2017). Glucose transporters in brain: In health and in Alzheimer’s disease. Journal of Alzheimer’s disease: JAD, 55(4), 1307–1320. https://doi.org/10.3233/jad-160841.
Takada, I., Kouzmenko, A. P., & Kato, S. (2009). Wnt and PPARgamma signaling in osteoblastogenesis and adipogenesis. Nature Reviews Rheumatology, 5(8), 442–447. https://doi.org/10.1038/nrrheum.2009.137.
Tefera, T. W., Tan, K. N., McDonald, T. S., & Borges, K. (2016). Alternative fuels in epilepsy and amyotrophic lateral sclerosis. Neurochemical Research. https://doi.org/10.1007/s11064-016-2106-7.
Thies, W. (2011). Stopping a thief and killer: Alzheimer’s disease crisis demands greater commitment to research. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, 7(2), 175–176. https://doi.org/10.1016/j.jalz.2011.02.002.
Thomas, B., & Beal, M. F. (2007). Parkinson’s disease. Human Molecular Genetics, 16(2), R183–R194. https://doi.org/10.1093/hmg/ddm159.
Thompson, C. B. (2014). Wnt meets Warburg: Another piece in the puzzle? The EMBO journal, 33(13), 1420–1422. https://doi.org/10.15252/embj.201488785.
Tillement, L., Lecanu, L., & Papadopoulos, V. (2011). Further evidence on mitochondrial targeting of β-amyloid and specificity of β-amyloid-induced mitotoxicity in neurons. Neuro-Degenerative Diseases, 8(5), 331–344. https://doi.org/10.1159/000323264.
Tsunemi, T., Ashe, T. D., Morrison, B. E., Soriano, K. R., Au, J., Roque, R. A. V., et al. (2012). PGC-1α rescues Huntington’s disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Science Translational Medicine, 4(142), 142–197. https://doi.org/10.1126/scitranslmed.3003799.
Vaishnavi, S. N., Vlassenko, A. G., Rundle, M. M., Snyder, A. Z., Mintun, M. A., & Raichle, M. E. (2010). Regional aerobic glycolysis in the human brain. Proceedings of the National Academy of Sciences of the United States of America, 107(41), 17757–17762. https://doi.org/10.1073/pnas.1010459107.
Valbuena, G. N., Rizzardini, M., Cimini, S., Siskos, A. P., Bendotti, C., Cantoni, L., et al. (2016). Metabolomic analysis reveals increased aerobic glycolysis and amino acid deficit in a cellular model of amyotrophic lateral sclerosis. Molecular Neurobiology, 53(4), 2222–2240. https://doi.org/10.1007/s12035-015-9165-7.
Vallée, A., Guillevin, R., & Vallée, J.-N. (2018a). Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas. Reviews in the Neurosciences, 29(1), 71–91. https://doi.org/10.1515/revneuro-2017-0032.
Vallée, A., & Lecarpentier, Y. (2016). Alzheimer disease: Crosstalk between the canonical Wnt/beta-catenin pathway and PPARs alpha and gamma. Frontiers in Neuroscience, 10, 459. https://doi.org/10.3389/fnins.2016.00459.
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017a). Thermodynamics in gliomas: Interactions between the Canonical WNT/beta-catenin pathway and PPAR gamma. Frontiers in Physiology, 8, 352. https://doi.org/10.3389/fphys.2017.00352.
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017b). Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis. Oncotarget, 8(52), 90579–90604. https://doi.org/10.18632/oncotarget.21234.
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017c). PPARγ agonists: Potential treatments for exudative age-related macular degeneration. Life Sciences, 188, 123–130. https://doi.org/10.1016/j.lfs.2017.09.008.
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017d). Aerobic glycolysis hypothesis through WNT/beta-catenin pathway in exudative age-related macular degeneration. Journal of Molecular Neuroscience: MN, 62(3–4), 368–379. https://doi.org/10.1007/s12031-017-0947-4.
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2017e). Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer’s disease. Acta Biochimica et Biophysica Sinica, 49(10), 853–866. https://doi.org/10.1093/abbs/gmx073.
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018b). Aerobic glycolysis in amyotrophic lateral sclerosis and Huntington’s disease. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2017-0075.
Vallée, A., Lecarpentier, Y., Guillevin, R., & Vallée, J.-N. (2018c). Reprogramming energetic metabolism in Alzheimer’s disease. Life Sciences, 193, 141–152. https://doi.org/10.1016/j.lfs.2017.10.033.
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2017f). Thermodynamic aspects and reprogramming cellular energy metabolism during the fibrosis process. International Journal of Molecular Sciences, 18(12), 2537. https://doi.org/10.3390/ijms18122537.
Vallée, A., Vallée, J.-N., Guillevin, R., & Lecarpentier, Y. (2017g). Interactions between the canonical WNT/beta-catenin pathway and PPAR gamma on neuroinflammation, demyelination, and remyelination in multiple sclerosis. Cellular and Molecular Neurobiology. https://doi.org/10.1007/s10571-017-0550-9.
Valvezan, A. J., & Klein, P. S. (2012). GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Frontiers in Molecular Neuroscience, 5, 1. https://doi.org/10.3389/fnmol.2012.00001.
van Wamelen, D. J., Aziz, N. A., Anink, J. J., van Steenhoven, R., Angeloni, D., Fraschini, F., et al. (2013). Suprachiasmatic nucleus neuropeptide expression in patients with Huntington’s Disease. Sleep, 36(1), 117–125. https://doi.org/10.5665/sleep.2314.
Videnovic, A., & Golombek, D. (2013). Circadian and sleep disorders in Parkinson’s disease. Experimental Neurology, 243, 45–56. https://doi.org/10.1016/j.expneurol.2012.08.018.
Videnovic, A., & Willis, G. L. (2016). Circadian system—A novel diagnostic and therapeutic target in Parkinson’s disease? Movement Disorders: Official Journal of the Movement Disorder Society, 31(3), 260–269. https://doi.org/10.1002/mds.26509.
Videnovic, A., & Zee, P. C. (2015). Consequences of circadian disruption on neurologic health. Sleep Medicine Clinics, 10(4), 469–480. https://doi.org/10.1016/j.jsmc.2015.08.004.
Vlassenko, A. G., Vaishnavi, S. N., Couture, L., Sacco, D., Shannon, B. J., Mach, R. H., et al. (2010). Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proceedings of the National Academy of Sciences of the United States of America, 107(41), 17763–17767. https://doi.org/10.1073/pnas.1010461107.
Wan, W., Xia, S., Kalionis, B., Liu, L., & Li, Y. (2014). The role of Wnt signaling in the development of Alzheimer’s disease: A potential therapeutic target? BioMed Research International, 2014, 301575. https://doi.org/10.1155/2014/301575.
Wang, S., Guan, Y., Chen, Y., Li, X., Zhang, C., Yu, L., et al. (2013). Role of Wnt1 and Fzd1 in the spinal cord pathogenesis of amyotrophic lateral sclerosis-transgenic mice. Biotechnology Letters, 35(8), 1199–1207. https://doi.org/10.1007/s10529-013-1199-1.
Wang, Q., Liu, Y., & Zhou, J. (2015). Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Translational Neurodegeneration, 4, 19. https://doi.org/10.1186/s40035-015-0042-0.
Wang, X., Sirianni, A., Pei, Z., Cormier, K., Smith, K., Jiang, J., et al. (2011). The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31(41), 14496–14507. https://doi.org/10.1523/jneurosci.3059-11.2011.
Wang, X., Wang, Y., Hu, J.-P., Yu, S., Li, B.-K., Cui, Y., et al. (2017). Astragaloside IV, a natural PPARγ agonist, reduces Aβ production in Alzheimer’s disease through inhibition of BACE1. Molecular Neurobiology, 54(4), 2939–2949. https://doi.org/10.1007/s12035-016-9874-6.
Wang, N., Yang, G., Jia, Z., Zhang, H., Aoyagi, T., Soodvilai, S., et al. (2008). Vascular PPARgamma controls circadian variation in blood pressure and heart rate through Bmal1. Cell Metabolism, 8(6), 482–491. https://doi.org/10.1016/j.cmet.2008.10.009.
Wang, H.-M., Zhao, Y.-X., Zhang, S., Liu, G.-D., Kang, W.-Y., Tang, H.-D., et al. (2010). PPARgamma agonist curcumin reduces the amyloid-beta-stimulated inflammatory responses in primary astrocytes. Journal of Alzheimer’s disease: JAD, 20(4), 1189–1199. https://doi.org/10.3233/jad-2010-091336.
Warburg, O. (1956). On the origin of cancer cells. Science (New York, N.Y.), 123(3191), 309–314.
Weishaupt, J. H., Bartels, C., Pölking, E., Dietrich, J., Rohde, G., Poeggeler, B., et al. (2006). Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. Journal of Pineal Research, 41(4), 313–323. https://doi.org/10.1111/j.1600-079X.2006.00377.x.
Wenz, T., Diaz, F., Spiegelman, B. M., & Moraes, C. T. (2008). Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metabolism, 8(3), 249–256. https://doi.org/10.1016/j.cmet.2008.07.006.
Wiedau-Pazos, M., Wong, E., Solomon, E., Alarcon, M., & Geschwind, D. H. (2009). Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice. Neurobiology of Aging, 30(1), 14–21. https://doi.org/10.1016/j.neurobiolaging.2007.05.015.
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., et al. (2008). Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences of the United States of America, 105(48), 18782–18787. https://doi.org/10.1073/pnas.0810199105.
Wisor, J. P., Edgar, D. M., Yesavage, J., Ryan, H. S., McCormick, C. M., Lapustea, N., et al. (2005). Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer’s disease: a role for cholinergic transmission. Neuroscience, 131(2), 375–385. https://doi.org/10.1016/j.neuroscience.2004.11.018.
Wood-Kaczmar, A., Gandhi, S., Yao, Z., Abramov, A. Y., Abramov, A. S. Y., Miljan, E. A., et al. (2008). PINK1 is necessary for long term survival and mitochondrial function in human dopaminergic neurons. PLoS ONE, 3(6), e2455. https://doi.org/10.1371/journal.pone.0002455.
Wu, Y.-H., Fischer, D. F., Kalsbeek, A., Garidou-Boof, M.-L., van der Vliet, J., van Heijningen, C., et al. (2006). Pineal clock gene oscillation is disturbed in Alzheimer’s disease, due to functional disconnection from the “master clock”. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 20(11), 1874–1876. https://doi.org/10.1096/fj.05-4446fje.
Wu, D., & Pan, W. (2010). GSK3: A multifaceted kinase in Wnt signaling. Trends in Biochemical Sciences, 35(3), 161–168.
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., et al. (1999). Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 98(1), 115–124. https://doi.org/10.1016/S0092-8674(00)80611-X.
Wu, Y.-H., & Swaab, D. F. (2005). The human pineal gland and melatonin in aging and Alzheimer’s disease. Journal of Pineal Research, 38(3), 145–152. https://doi.org/10.1111/j.1600-079X.2004.00196.x.
Wulf, G., Finn, G., Suizu, F., & Lu, K. P. (2005). Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nature Cell Biology, 7(5), 435–441. https://doi.org/10.1038/ncb0505-435.
Wyse, C. A., & Coogan, A. N. (2010). Impact of aging on diurnal expression patterns of CLOCK and BMAL1 in the mouse brain. Brain Research, 1337, 21–31. https://doi.org/10.1016/j.brainres.2010.03.113.
Xiong, H., Callaghan, D., Jones, A., Walker, D. G., Lue, L.-F., Beach, T. G., et al. (2008). Cholesterol retention in Alzheimer’s brain is responsible for high beta- and gamma-secretase activities and Abeta production. Neurobiology of Disease, 29(3), 422–437. https://doi.org/10.1016/j.nbd.2007.10.005.
Xu, C., Wang, J., Zhu, T., Shen, Y., Tang, X., Fang, L., et al. (2016). Cross-talking between PPAR and WNT signaling and its regulation in mesenchymal stem cell differentiation. Current Stem Cell Research & Therapy, 11(3), 247–254.
Yaffe, M. B., Schutkowski, M., Shen, M., Zhou, X. Z., Stukenberg, P. T., Rahfeld, J. U., et al. (1997). Sequence-specific and phosphorylation-dependent proline isomerization: A potential mitotic regulatory mechanism. Science (New York, N.Y.), 278(5345), 1957–1960.
Yang, X., Downes, M., Yu, R. T., Bookout, A. L., He, W., Straume, M., et al. (2006). Nuclear receptor expression links the circadian clock to metabolism. Cell, 126(4), 801–810. https://doi.org/10.1016/j.cell.2006.06.050.
Yang, G., Jia, Z., Aoyagi, T., McClain, D., Mortensen, R. M., & Yang, T. (2012a). Systemic PPARγ deletion impairs circadian rhythms of behavior and metabolism. PLoS ONE, 7(8), e38117. https://doi.org/10.1371/journal.pone.0038117.
Yang, S.-H., Li, W., Sumien, N., Forster, M., Simpkins, J. W., & Liu, R. (2015). Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots. Progress in Neurobiology. https://doi.org/10.1016/j.pneurobio.2015.10.005.
Yang, X., Wood, P. A., Ansell, C. M., Ohmori, M., Oh, E.-Y., Xiong, Y., et al. (2009). Beta-catenin induces beta-TrCP-mediated PER2 degradation altering circadian clock gene expression in intestinal mucosa of ApcMin/+ mice. Journal of Biochemistry, 145(3), 289–297. https://doi.org/10.1093/jb/mvn167.
Yang, W., Xia, Y., Hawke, D., Li, X., Liang, J., Xing, D., et al. (2012b). PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell, 150(4), 685–696. https://doi.org/10.1016/j.cell.2012.07.018.
Yasuniwa, Y., Izumi, H., Wang, K.-Y., Shimajiri, S., Sasaguri, Y., Kawai, K., et al. (2010). Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway. PLoS ONE, 5(12), e15330. https://doi.org/10.1371/journal.pone.0015330.
Yin, F., Boveris, A., & Cadenas, E. (2014). Mitochondrial energy metabolism and redox signaling in brain aging and neurodegeneration. Antioxidants & Redox Signaling, 20(2), 353–371. https://doi.org/10.1089/ars.2012.4774.
Yuan, S., Shi, Y., & Tang, S.-J. (2012). Wnt signaling in the pathogenesis of multiple sclerosis-associated chronic pain. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 7(4), 904–913. https://doi.org/10.1007/s11481-012-9370-3.
Yue, X., Lan, F., Yang, W., Yang, Y., Han, L., Zhang, A., et al. (2010). Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells. Brain Research, 1366, 27–37. https://doi.org/10.1016/j.brainres.2010.10.032.
Yujnovsky, I., Hirayama, J., Doi, M., Borrelli, E., & Sassone-Corsi, P. (2006). Signaling mediated by the dopamine D2 receptor potentiates circadian regulation by CLOCK:BMAL1. Proceedings of the National Academy of Sciences of the United States of America, 103(16), 6386–6391. https://doi.org/10.1073/pnas.0510691103.
Zhang, S., Hulver, M. W., McMillan, R. P., Cline, M. A., & Gilbert, E. R. (2014). The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility. Nutrition & Metabolism, 11(1), 10. https://doi.org/10.1186/1743-7075-11-10.
Zhang, Z.-X., Li, Y.-B., & Zhao, R.-P. (2017). Epigallocatechin gallate attenuates β-amyloid generation and oxidative stress involvement of PPARγ in N2a/APP695 cells. Neurochemical Research, 42(2), 468–480. https://doi.org/10.1007/s11064-016-2093-8.
Zhang, H.-M., & Zhang, Y. (2014). Melatonin: A well-documented antioxidant with conditional pro-oxidant actions. Journal of Pineal Research, 57(2), 131–146. https://doi.org/10.1111/jpi.12162.
Zhang, K., Zhang, J., Han, L., Pu, P., & Kang, C. (2012). Wnt/beta-catenin signaling in glioma. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 7(4), 740–749. https://doi.org/10.1007/s11481-012-9359-y.
Zhao, X., Strong, R., Zhang, J., Sun, G., Tsien, J. Z., Cui, Z., et al. (2009). Neuronal PPARgamma deficiency increases susceptibility to brain damage after cerebral ischemia. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 29(19), 6186–6195. https://doi.org/10.1523/JNEUROSCI.5857-08.2009.
Zhou, W., Cai, F., Li, Y., Yang, G. S., O’Connor, K. D., Holt, R. A., et al. (2010). BACE1 gene promoter single-nucleotide polymorphisms in Alzheimer’s disease. Journal of Molecular Neuroscience: MN, 42(1), 127–133. https://doi.org/10.1007/s12031-010-9381-6.
Zhou, T., Zu, G., Zhang, X., Wang, X., Li, S., Gong, X., et al. (2016). Neuroprotective effects of ginsenoside Rg1 through the Wnt/β-catenin signaling pathway in both in vivo and in vitro models of Parkinson’s disease. Neuropharmacology, 101, 480–489. https://doi.org/10.1016/j.neuropharm.2015.10.024.
Zuo, L., Hemmelgarn, B. T., Chuang, C.-C., & Best, T. M. (2015). The role of oxidative stress-induced epigenetic Alterations in amyloid-β production in Alzheimer’s disease. Oxidative Medicine and Cellular Longevity, 2015, 604658. https://doi.org/10.1155/2015/604658.
Author information
Authors and Affiliations
Contributions
All authors listed, have made contribution to the work, and approved it for submission to publication.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest.
Rights and permissions
About this article
Cite this article
Vallée, A., Lecarpentier, Y., Guillevin, R. et al. Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway–PPAR Gamma, Energy Metabolism and Circadian Rhythms. Neuromol Med 20, 174–204 (2018). https://doi.org/10.1007/s12017-018-8486-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12017-018-8486-x